Document:

Form of Option Agreement

 Exhibit 10.16 
 NONQUALIFIED STOCK OPTION AGREEMENT 
 AGREEMENT by and between SUNSHINE SILVER MINES
CORPORATION, a Delaware corporation (the “Company”), and                          (the
“Optionee”). 
 Pursuant to the Sunshine Silver Mines Corporation Long Term Incentive Plan (as it may be further amended from
time to time, the “Plan”), and as required by the Employment Agreement between the Company and the Optionee dated
                     (the “Employment Agreement”), the Company desires to grant to the Optionee, and the Optionee desires to accept
from the Company, an option to purchase shares of the common stock of the Company, par value $.001 per share (the “Common Stock”), upon the terms and conditions set forth in this Agreement. 

NOW, THEREFORE, the Company and the Optionee agree as follows: 
 1. Grant of Initial Options and Regular Options; Option Price. Effective                     
(the “Grant Date”), the Company hereby grants to the Optionee options to purchase                         
shares of Common Stock (the “Initial Options”) and options to purchase                          shares of Common
Stock (the “Regular Options”; the Initial Options and the Regular Options, collectively, the “Options”). The Options are intended to be treated as options that are not incentive stock options within the meaning of
Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”). 
 There are potential tax consequences
associated with the grant, vesting and exercise of the Options. It is the responsibility of the Optionee to seek independent tax advice with regard to the tax treatment of the Options, the exercise thereof, the disposition of any Common Stock
acquired upon exercise of the Options and any other related matters. 
 2. Option Price. The purchase price for each Option is
$            , and upon exercise each Option entitles the holder to acquire one share of Common Stock. The purchase price per Option is not less than the fair market value of a share of
Common Stock on the Grant Date. 
 3. Entitlement to Exercise Option; Term of Option. 

(a) Subject to the terms of this Agreement and the Plan, the Options shall only become exercisable in accordance with the following vesting schedule,
provided that the Optionee has been in Continuous Service following                          (the “Vesting Start
Date”): 
  

					
	 Vesting Date
	  	Percent of Initial
Options Vested	  	Percent of Regular
Options Vested
	 First Anniversary of Vesting Start Date
	  		  	
	 Second Anniversary of Vesting Start Date
	  		  	

			
	Sunshine Silver Mines Corporation Long Term Incentive Plan	  	NQSO Agreement

  

					
	 Third Anniversary of Vesting Start Date
	 		 	

 Except as provided in paragraphs (b) and (c) below, options shall become exerciseable on the vesting date shown
in the table above. 
 Unless sooner terminated pursuant to the terms of this Agreement, the Options will expire if and to the extent not
exercised on or before the tenth anniversary of the Grant Date. 
 (b) Notwithstanding the foregoing, if the Optionee’s Continuous Service
terminates by death or Disability (as defined in the Employment Agreement) prior to any Option vesting, then all Options whether or not then exerciseable shall then immediately vest and become exercisable. 

(c) Notwithstanding the foregoing, if the Company terminates the Optionee’s Continuous Service without Cause (as defined in the Employment
Agreement) or the Optionee terminates his employment for Good Reason (as defined in the Employment Agreement), any Initial Options which remain unvested shall immediately vest and become exerciseable, but any Regular Options which remain unvested
shall cease vesting. 
 4. Exercise of Option; Method of Payment. (a) Subject to the requirements of Section 2, vested Options
may be exercised at any time or from time to time prior to their expiry date. To exercise the Option, the Optionee shall deliver to the Chief Executive Officer of the Company: (i) a written notice specifying the number of Options to be
exercised, and (ii) payment in full of the exercise price, together with the amount, if any, deemed necessary by the Company to enable it to satisfy any income tax withholding obligations with respect to the exercise of the Options or the sale
of the shares of Common Stock covered thereby. 
 (b) The method of payment for exercising Options may be one or a combination of the following:
(i) cash or check payable in clearinghouse funds to the order of the Company; (ii) by delivery to the Company of other shares of Common Stock which, unless otherwise determined by the Committee, have been held for more than six
(6) months; (iii) if permitted by the Company, by a “net exercise” arrangement (as described in the Plan); or (iv) any other form of legal consideration that may be acceptable to the Committee. If the Company determines that
any federal, state, local or foreign tax or withholding payment is required relating to the exercise of an Option or the sale of the shares of Common Stock covered thereby, then before the issuance of shares to the Optionee upon exercise of an
Option the Company shall have the right to require such payments from the Optionee or withhold such amounts from other payments due to the Company by the Optionee. 
 (c) The Optionee shall deliver the signed agreement, in the form provided in Exhibit A, as a condition of exercise of any Options. 
 5. Rights as a Stockholder. No shares of Common Stock will be issued or delivered pursuant to an exercise of an Option until full payment for such shares has been made and arrangements to satisfy
tax withholding requirements have been made to the satisfaction of the Company pursuant to Section 16 of the Plan. The Optionee shall not be deemed to be, or have 

  
 2 

			
	Sunshine Silver Mines Corporation Long Term Incentive Plan	  	NQSO Agreement

  

 
any rights as, a stockholder with respect to any shares covered by the Options until a stock certificate for such shares has been issued to the Optionee. Except as otherwise provided herein, no
adjustment shall be made for dividends or distributions or other rights for which the record date is prior to the date of issuance of such stock certificate. 
 6. Nontransferability of Option. The Options are not assignable or transferable except by will or by the applicable laws of descent and distribution. The Options are exercisable during the
Optionee’s lifetime only by the Optionee or in the case of Disability, by the Optionee’s legal guardian. 
 7.
Period to Exercise After Termination of Employment. If the Optionee’s Continuous Service with the Company or any Subsidiary terminates by reason of the Optionee’s termination without Cause or termination by Optionee for Good Reason,
then, unless sooner terminated under the terms hereof or pursuant to the Plan, the Options will terminate on the
180th day after the date of the Optionee’s
termination of Continuous Service. If the Optionee’s Continuous Service with the Company or any Subsidiary terminates by reason of the Optionee’s death or Disability, then, unless sooner terminated under the terms hereof or pursuant to the
Plan, the Options will continue to be exercisable for a period of twelve (12) months from the date of the Optionee’s death or Disability. If the Optionee’s Continuous Service terminates by reason of the Optionee’s resignation
without Good Reason, the Options will terminate on the
30th day after such termination of the Optionee’s
Continuous Service. Notwithstanding any other provision of this Agreement, if the Optionee’s Continuous Service terminates by reason of the Optionee’s termination for Cause, the Options will cease to be exercisable and will be forfeited.
During any period following the termination of the Optionee’s Continuous Service in which the Options remain exercisable and during which the shares of Common Stock are not publicly traded, the Company may, in its sole discretion cancel such
Option by paying the Optionee the difference between (i) the Fair Market Value of the shares of Common Stock subject to the Options and (ii) the purchase price of the Options. For this purpose, Fair Market Value will be determined in
accordance with Section 3(c)(ii) of the attached Exercise Notice and Restricted Stock Purchase Agreement. 
 8. Plan Provisions
Control. This Agreement is subject to the terms and conditions of the Plan, which are incorporated herein by reference. Notwithstanding anything to the contrary contained herein, the provisions of the Plan shall govern if and to the extent that
there are inconsistencies between the provisions of the Plan and the provisions of this Agreement. The Optionee acknowledges that the Optionee has received a copy of the Plan prior to the execution of this Agreement. Capitalized terms not otherwise
defined herein shall have the same meanings set forth in the Plan for such terms. 
 9. No Rights Conferred. Nothing in this Agreement
shall give the Optionee any right to continue in the employ or service of the Company or any Subsidiary and/or as a member of the Company’s Board of Directors or in any other capacity, or interfere in any way with the right of the Company or
any Subsidiary to terminate the employment or services of the Optionee. 
 10. Change of Control; Adjustments. The provisions of
Section 8 of the Plan shall govern upon the consummation of a Change of Control. All references to the number and class of shares covered by this Agreement, the exercise price per share of each Option, and other terms in this

  
 3 

			
	Sunshine Silver Mines Corporation Long Term Incentive Plan	  	NQSO Agreement

  

 
Agreement may be appropriately adjusted, in the discretion of the Committee, in the event of certain changes in capitalization, as set forth in Section 9 of the Plan. 

11. Securities Law and Other Requirements. Exercise of an Option is subject to compliance with applicable securities and other laws, rules and
regulations, including without limitation as set forth in Section 15 of the Plan, and the Company may defer exercise of an Option to ensure compliance with such laws, rules and regulations. 

12. Binding Effect. This Agreement shall be binding upon and shall inure to the benefit of the parties hereto and their respective heirs,
executors, administrators, successors and permitted assigns. This Agreement may not be assigned or transferred in whole or in part except as provided in the Plan. 
 13. Interpretation of this Agreement. All determinations and interpretations made by the Committee with regard to any questions arising under the Plan or this Agreement shall be final, binding and
conclusive as to all persons, including without limitation the Optionee and any person claiming rights from or through the Optionee. 
 14.
Dispute Resolution and Arbitration. The Company and the Optionee shall attempt in good faith to resolve any dispute arising out of or relating to this Agreement promptly by negotiation. If the matter has not been resolved within thirty
(30) calendar days of a party’s request for negotiation, either party may initiate proceedings or arbitration only as provided herein. If any dispute arising out of or relating to this Agreement or the breach, termination or validity
thereof has not been resolved by negotiation, such dispute shall be settled by binding arbitration in accordance with the then current rules of JAMS by a single independent and impartial arbitrator who is located in Denver, Colorado. The arbitrator
selected must have an expertise in the matter(s) in dispute. Each party shall bear his/its own fees and costs; the fees, costs and all administrative expenses of arbitration shall be borne equally by the Company and the Optionee. The parties
understand and agree that the arbitration is subject to the rules of JAMS; that the arbitrator’s decision and award shall be final and binding as to all claims that were, or could have been, raised in arbitration; and that judgment upon the
award rendered by the arbitrator may be entered in any court having competent jurisdiction. Any award rendered hereunder may include an award of attorneys’ fees and costs but shall not include punitive damages. The statute of limitations of the
state of New York applicable to the commencement of a lawsuit shall apply to the commencement of an arbitration. 
 15. Governing Law; Entire
Agreement. This Agreement shall be governed by and construed in accordance with the Laws of the State of New York (including Section 5-1401 of the General Obligations Law of the State of New York but otherwise without regard to conflicts of
laws principles). The Plan and this Agreement constitute the entire agreement between the parties with respect to the subject matter hereof and supersede all prior understandings and agreements, written or oral, of the parties hereto with respect to
the subject matter hereof. This Agreement may be amended by the Committee, subject to the Optionee’s consent if such amendment is not favorable to the Optionee, except that the consent of the Optionee shall not be required for any amendment
made pursuant to Section 8 or Section 9 of the Plan. 

  
 4 

			
	Sunshine Silver Mines Corporation Long Term Incentive Plan	  	NQSO Agreement

  

 IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the date first written above.

  

			
	SUNSHINE SILVER MINES CORPORATION
		
	By:	 	  

		
	Name:	 	  

		
	Title:	 	  

	
	Optionee:
	
	  

  
 5 

			
	Sunshine Silver Mines Corporation Long Term Incentive Plan	  	NQSO Agreement

  

 EXHIBIT A 
 SUNSHINE SILVER MINES CORPORATION 
 STOCK OPTION AND LONG TERM INCENTIVE
PLAN 
 EXERCISE NOTICE AND RESTRICTED STOCK PURCHASE AGREEMENT 

This Agreement (“Agreement”) is made as of
                    , by and between Sunshine Silver Mines Corporation, a Delaware corporation (the “Company”), and
«Optionee» (“Purchaser”). To the extent any capitalized terms used in this Agreement are not defined, they shall have the meaning ascribed to them in the Company’s Stock Option and Long Term Incentive Plan (the
“Plan”). 
 1. Exercise of Option. Subject to the terms and conditions hereof, Purchaser hereby
elects to exercise options to purchase                      shares of the Common Stock (the “Shares”) of the Company under and
pursuant to the Plan and the Stock Option Agreement granted on                              ,
         (the “Option Agreement”). The purchase price for the Shares shall be $             per Share for a total purchase price of
$            . The term “Shares” refers to the purchased Shares and all securities received in replacement of the Shares or as stock dividends or splits, all securities
received in replacement of the Shares in a recapitalization, merger, reorganization, exchange or the like, and all new, substituted or additional securities or other properties to which Purchaser is entitled by reason of Purchaser’s ownership
of the Shares. 
 2. Time and Place of Exercise. The purchase and sale of the Shares under this Agreement shall
occur at the principal office of the Company simultaneously with the execution and delivery of this Agreement in accordance with the provisions of Section 4 of the Option Agreement. On such date, the Company will deliver to Purchaser a
certificate representing the Shares to be purchased by Purchaser (which shall be issued in Purchaser’s name) against payment of the exercise price therefor by Purchaser by any method listed in Section 4 of the Option Agreement. 

3. Limitations on Transfer. In addition to any other limitation on transfer created by applicable securities laws,
Purchaser shall not assign, encumber or dispose of any interest in the Shares except in compliance with the provisions below and applicable securities laws. 
 (a) Private Company. Purchaser acknowledges that the Company shall have the right, but not the obligation, at any time following the termination of Purchaser’s Continuous Service for
any reason or after exercise of an Option if the Option is exercised after termination of Purchaser’s Continuous Service for any reason, to repurchase all or part of the Shares (the “Repurchase Right”). The repurchase price
shall be the Fair Market Value of those Shares as of the date the Repurchase Right is exercised. The Fair Market Value per Share will be determined as set forth in Section 3(c)(ii) of this Agreement. 

  
 6 

			
	Sunshine Silver Mines Corporation Long Term Incentive Plan	  	NQSO Agreement

  

 (i) Procedure. The Repurchase Right shall be exercised by
the Company or its assigns by giving Purchaser written notice of the Company’s intention to exercise the Repurchase Right. Upon such notification, Purchaser shall promptly surrender to the Company, free and clear of any liens or encumbrances,
any certificates representing the Shares being purchased, together with a duly executed stock power for the transfer of such Shares to the Company or the Company’s assignee or assignees. Upon the Company’s or its assignee’s receipt of
the certificates from Purchaser, the Company or its assignee or assignees shall, as soon as practicable following the determination of the Fair Market Value of the shares of Common Stock being purchased, (1) deliver to Purchaser a check in the
amount of the aggregate Repurchase Price, (2) cancel an amount of Purchaser’s indebtedness to the Company, if any, equal to the Repurchase Price, or (3) by a combination of (1) and (2) so that the combined payment,
cancellation of indebtedness and face value of the promissory note equals the Repurchase Price. Upon delivery of such notice and the payment of the Repurchase Price (by one of the methods specified in the previous sentence), the Company shall become
the legal and beneficial owner of the Shares being repurchased and all rights and interests therein or relating thereto, and the Company shall have the right to retain and transfer to its own name the number of Shares being repurchased by the
Company. 
 (ii) Assignment of Repurchase Right. Whenever the Company shall have the right to
repurchase shares of Common Stock hereunder, the Company may designate and assign one or more employees, officers, directors or shareholders of the Company or other persons or organizations to exercise all or a part of the Company’s Repurchase
Right and purchase all or a part of such Shares. 
 (b) No Other Transfer Permitted. 

(i) General Rule. Except as otherwise permitted by the Company in writing or pursuant to
Section 3(b)(ii), no Shares held by Purchaser or any transferee of Purchaser may be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated, other than by will or by the laws of descent and distribution. 

(ii) Estate Planning Transfers. Notwithstanding any other provisions of the Plan and this Agreement to the
contrary, Purchaser may, with the consent of the Company, such consent not to be unreasonably withheld, assign the Shares for bona fide estate planning purposes by Purchaser to his issue, or to a trustee or trustees of a trust whose vested
beneficiaries then include any such of Purchaser’s kindred, if (i) the persons who would control the Shares and the proposed arrangements for the control of the Shares are reasonably satisfactory to the Company, including, without
limitation, that any Shares will remain subject to all of the forfeiture and transfer restrictions and conditions set forth herein and in the Plan and (ii) the requirements of the Securities Act of 1933, as amended (the “Securities
Act”) and any applicable state securities or blue sky laws are met. 
 (c) Involuntary Transfer.

  
 7 

			
	Sunshine Silver Mines Corporation Long Term Incentive Plan	  	NQSO Agreement

  

 (i) Company’s Right to Purchase upon Involuntary
Transfer. In the event, at any time after the date of this Agreement, of any transfer by operation of law or other involuntary transfer (including death or divorce) of all or a portion of the Shares by the record holder thereof, the Company
shall have an option to purchase all of the Shares transferred at the greater of the purchase price paid by Purchaser for the Shares pursuant to this Agreement (as adjusted for any stock splits, stock dividends and the like) or the Fair Market Value
of the Shares on the date of transfer. Upon such a transfer, the person acquiring the Shares shall promptly notify the Secretary of the Company of such transfer. The right to purchase such Shares shall be provided to the Company for a period of
thirty (30) days following receipt by the Company of written notice by the person acquiring the Shares. 

(ii) Price for Involuntary Transfer. With respect to any stock to be transferred pursuant to Sections 3(a)
or 3(c)(i), the Fair Market Value per Share shall be a price set by the Board of Directors of the Company (the “Board”) in good faith using a reasonable valuation method in a reasonable manner in accordance with Section 409A of
the Code. The Company shall notify Purchaser or his or her executor of the price so determined within thirty (30) days after receipt by it of written notice of the transfer or proposed transfer of Shares. The determination of the Fair Market
Value per Share by the Board shall be final and binding on all parties. 
 (d) Drag Along Right. 

(i) If the Required Holder (as defined below) approves the sale of the Company, whether by merger, consolidation, sale of
outstanding capital stock, sale of all or substantially all of its assets or otherwise (any of the foregoing, an “Approved Sale”), (1) Purchaser shall consent to, vote for and raise no objections against, and waive dissenters and
appraisal rights (if any) with respect to, the Approved Sale, (2) if the Approved Sale is structured as a sale of stock, Purchaser shall agree to sell and shall be permitted to sell all of Purchaser’s Shares on the terms and conditions
approved by the Required Holder, and (3) if the Approved Sale includes the sale, exchange, redemption, cancellation or other disposition of securities convertible into or exchangeable for capital stock of the Company, or options, warrants or
other rights to purchase such capital stock or securities, Purchaser shall sell, exchange, redeem, agree to cancel or otherwise dispose of such securities or options, warrants or other rights on the terms and conditions approved by the Required
Holder. In order to effect the covenant set forth in clause (1) of the immediately preceding sentence, Purchaser shall be deemed to have granted to the Company with respect to all of Purchaser’s Shares an irrevocable proxy (which is deemed
to be coupled with an interest) with respect to any stockholder vote or action by written consent solely to effect such Approved Sale in compliance with this Section 3(d). Purchaser shall take all necessary and desirable actions in connection
with the consummation of an Approved Sale. As used herein, the term “Required Holder” means, as of any date, any one or more of the Kaplan Parties. 
 (ii) The obligations of Purchaser with respect to an Approved Sale are subject to the satisfaction of the conditions that: (1) upon the consummation of the Approved Sale, all of the holders of Common
Stock shall receive the same form and 

  
 8 

			
	Sunshine Silver Mines Corporation Long Term Incentive Plan	  	NQSO Agreement

  

 
amount of consideration per share of Common Stock, or if any holder of Common Stock is given an option as to the form and amount of consideration to be received in respect of Common Stock, all
holders of Common Stock shall be given the same option; and (2) in the case of a holder of any securities referred to in clause (3) of paragraph (i) above, (I) in the event such securities are vested, the holder shall receive in
such Approved Sale, unless otherwise provided in the terms of any agreement or instrument governing or evidencing such security, either (x) the same securities or other property that such holder would have received if such holder had converted,
exchanged or exercised such security immediately prior to such Approved Sale (after taking into account the conversion, exchange or exercise price applying to such security and any applicable tax obligations of the holder in connection with such
conversion, exchange or exercise) or (y) a security convertible or exchangeable for, or option, warrant or right to purchase, capital stock or other securities of a successor entity having substantially equivalent value, or (II) in the case
where such securities are not vested, unless otherwise provided in the terms of any agreement or instrument governing or evidencing such security, such securities shall be cancelled. 

(iii) Purchaser shall be required to make substantially the same representations and warranties (but only to the extent
that such representations and warranties relate to Purchaser’s ownership of Shares and his authority to execute such documents), customary covenants and other agreements, to the extent reasonably related to the Approved Sale, as the Required
Holder has agreed to make in connection with the proposed Approved Sale. Purchaser acknowledges that his pro rata share (based upon the number of Shares owned by such holder) of the aggregate proceeds of an Approved Sale may be reduced by
transaction expenses related to such Approved Sale. Purchaser shall be obligated to join on a pro rata basis in any indemnification or other obligations that the Required Holder agrees to provide in connection with such Approved Sale; provided,
however, that Purchaser shall not be obligated in connection with such Approved Sale to agree to indemnify or hold harmless any person with respect to (1) the representations and warranties of any other holder of Common Stock regarding its
ownership of Common Stock or (2) an amount in excess of the net proceeds received by Purchaser in connection with such Approved Sale. 
 (e) Clawback of Shares on Termination For Cause. Purchaser acknowledges that in the event of termination of Purchaser’s Continuous Service status for Cause, the Committee shall have
authority to effect such procedures and take such actions as are necessary to carry out the legal intent of Section 10 of the Plan, including such procedures and actions as are required to cause Purchaser to return to the Company Shares
purchased under the Option that have been purchased or that vested within six months of the events giving rise to the for-Cause termination of Purchaser’s Continuous Service status and, if such Shares have been transferred by Purchaser, to
remit to the Company the value of such transferred Shares, also as set forth in Section 10 of the Plan. 
 (f)
Assignment. The right of the Company to purchase any part of the Shares may be assigned in whole or in part to any stockholder or stockholders of the Company or other persons or organizations. 

  
 9 

			
	Sunshine Silver Mines Corporation Long Term Incentive Plan	  	NQSO Agreement

  

 (g) Restrictions Binding on Transferees. All transferees of Shares or any
interest therein will receive and hold such Shares or interest subject to the provisions of this Agreement. Any sale or transfer of the Company’s Shares shall be void unless the provisions of this Agreement are satisfied. 

(h) Termination of Rights Following Initial Public Offering. The right of repurchase granted by the Company in
Section 3(a) above, the restrictions on transfer provided in Section 3(b) above, the option to repurchase the Shares in the event of an involuntary transfer granted the Company by Section 3(c) above and the drag-along right provided
in Section 3(d) above shall terminate upon the first sale of Common Stock of the Company to the general public pursuant to a registration statement filed with and declared effective by the Securities and Exchange Commission under the Securities
Act. Upon termination of the rights to repurchase and the right of first refusal described in Sections 3(a), 3(b), 3(c) and 3(d) above, a new certificate or certificates representing the Shares not repurchased shall be issued, on request, without
the legend referred to in Section 6(a)(ii) herein and delivered to Purchaser. 
 4. Taxation Representations.
In connection with the purchase of the Shares, Purchaser represents to the Company the following: 
 (a) Purchaser understands
that Purchaser may suffer adverse tax consequences as a result of Purchaser’s purchase or disposition of the Shares. Purchaser represents that Purchaser has consulted any tax consultants Purchaser deems advisable in connection with the purchase
or disposition of the Shares and that Purchaser is not relying on the Company for any tax advice. 
 (b) Purchaser understands
that the per share “Exercise Price” for the Options is intended to be at least equal to the fair market value of the Company’s Common Stock at the date of grant and that the Company has attempted in good faith to make the fair market
value determination in compliance with applicable tax law although there can be no certainty that the IRS will agree. Purchaser understands that if the IRS does not agree and asserts that the fair market value at the time of grant is higher than the
Exercise Price, the IRS could seek to impose greater taxes on Purchaser, including, without limitation, interest and penalties under Internal Revenue Code Section 409A. 
 5. Regulation D Representations.1 Purchaser hereby makes the following representations and warranties to the Company as of the date hereof: 
 (a) Experience; Status. 
  

	1 	For Rule 701 awards, replace (a) and (b) of Section 5 with the following: 

5. Rule 701 Representations. (a) Purchaser represents that he is an employee, director, general partner, officer, consultant
or advisor of the Company or its Subsidiaries. Additionally, if Purchaser is a consultant or advisor described in the preceding sentence, Purchaser represents that (i) he is a natural person; (ii) he provides bona fide services to the
Company or its Subsidiaries; and (iii) the services are not in connection with the offer or sale of securities in a capital-raising transaction, and do not directly or indirectly promote or maintain a market for the Company’s securities.

  
 10 

			
	Sunshine Silver Mines Corporation Long Term Incentive Plan	  	NQSO Agreement

  

 (i) Purchaser has experience in analyzing and investing in companies
like the Company and is capable of evaluating the merits and risks of its investment in the Company and has the capacity to protect its own interests. To the extent necessary, Purchaser has retained, at its own expense, and relied upon, appropriate
professional advice regarding the investment, tax and legal merits and consequences of the Shares, it being understood that the Company has not retained legal or financial advisors on behalf of Purchaser. 

(ii) Purchaser is an Accredited Investor (as such term is used in Rule 501 under the Securities Act), is able to bear the
economic risk of its investment in the Company and has sufficient net worth to sustain a loss of its entire investment in the Company without economic hardship if such loss should occur. The Questionnaire attached hereto as Annex 1 and completed by
Purchaser is true and correct and incorporated herein by reference. 
 (b) Access to Company Information.

 (i) Purchaser has had an opportunity to discuss the Company’s business, management and financial affairs
with the members of the Company’s management and has had the opportunity to review the Company’s facilities. Purchaser has also had an opportunity to ask questions of the officers of the Company, which questions were answered to its
satisfaction. Purchaser acknowledges that it is familiar with all aspects of the Company’s business. 
 (ii)
Purchaser has received no representations or warranties from the Company, or its employees, affiliates, attorneys, accountants or agents. 
 (iii) Purchaser understands that an investment in the Company involves numerous risks. 
 (c) Investment Purposes; Rule 144. 
 (i) Purchaser is
acquiring the Shares solely for investment for Purchaser’s own account, not as a nominee or agent, and not with the view to, or for resale in connection with, any distribution thereof. Purchaser understands that the Shares have not been
registered under the Securities Act or applicable state and other securities laws by reason of a specific exemption from the registration provisions of the Securities Act and applicable state and other securities laws, the availability of which
depends upon, among other things, the bona fide nature of the investment intent and the accuracy of Purchaser’s representations as expressed herein. Purchaser understands that the Company is relying, in part, upon the representations and
warranties contained in this agreement for the purpose of determining whether this transaction meets the requirements for such exemptions. 
 (ii) Purchaser acknowledges and understands that Purchaser must bear the economic risk of Purchaser’s investment in the Shares for an indefinite period of time because the Shares are not transferable
except in very limited circumstances and must be held indefinitely unless subsequently registered under the Securities Act and applicable 

  
 11 

			
	Sunshine Silver Mines Corporation Long Term Incentive Plan	  	NQSO Agreement

  

 
state and other securities laws or unless an exemption from such registration is available. Purchaser understands that the Company has not agreed to and does not plan to file a registration
statement to register the resale of the Shares and any securities to be received in respect thereof under the Securities Act. 
 (iii) Purchaser is aware of the current provisions of Rule 144 promulgated under the Securities Act which permit resale of securities purchased in a private placement subject to the satisfaction of
certain conditions, including, among other things, the availability of certain current public information about the issuer of the securities and the resale occurring not less than one year after a party has purchased from an issuer or its affiliate
and paid the full purchase price for the securities to be sold. Purchaser understands that if the Company otherwise agrees to a transfer of the Shares, the Company will not transfer and any transfer agent of the Company will be issued stop-transfer
instructions with respect to such Shares unless such transfer is subsequently registered under the Securities Act and applicable state and other securities laws or unless an exemption from such registration is available. 

6. Restrictive Legends and Stop-Transfer Orders. 
 (a) Legends. The certificate or certificates representing the Shares shall bear the following legends (as well as any legends required by applicable state and federal corporate and
securities laws): 
 (i) THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES
ACT OF 1933, AS AMENDED, AND HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH TRANSFER MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN
OPINION OF COUNSEL IN A FORM SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933, AS AMENDED OR UNDER ANOTHER EXEMPTION AVAILABLE UNDER THE SECURITIES ACT OF 1933, AS AMENDED. 

(ii) THE SHARES REPRESENTED BY THIS CERTIFICATE MAY BE TRANSFERRED ONLY IN ACCORDANCE WITH THE TERMS OF AN AGREEMENT
BETWEEN THE COMPANY AND THE STOCKHOLDER, A COPY OF WHICH IS ON FILE WITH THE SECRETARY OF THE COMPANY. 
 (b)
Stop-Transfer Notices. Purchaser agrees that, in order to ensure compliance with the restrictions referred to herein, the Company may issue appropriate “stop transfer” instructions to its transfer agent, if any, and
that, if the Company transfers its own securities, it may make appropriate notations to the same effect in its own records. 

(c) Refusal to Transfer. The Company shall not be required (i) to transfer on its books any Shares that have been sold
or otherwise transferred in violation of any of the provisions of this Agreement or (ii) to treat as owner of such Shares or to accord the right to vote 

  
 12 

			
	Sunshine Silver Mines Corporation Long Term Incentive Plan	  	NQSO Agreement

  

 
or pay dividends to any purchaser or other transferee to whom such Shares shall have been so transferred. 
 7. No Employment Rights. Nothing in this Agreement shall affect in any manner whatsoever the right or power of the Company, or a parent or subsidiary of the Company, to terminate
Purchaser’s employment or consulting relationship, for any reason, with or without Cause. 
 8. Lock-Up
Agreement. In connection with the initial public offering of the Company’s securities and upon request of the Company or the underwriters managing any underwritten offering of the Company’s securities, Purchaser agrees not to lend,
offer, pledge, contract to sell, sell any option or contract to transfer, purchase any option or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer, directly or indirectly, any securities of the Company owned
immediately before the effective date of the registration statement for such offering (other than a sale of any securities of the Company to an underwriter pursuant to an underwriting agreement if all officers, directors and stockholders of more
than five percent of the Company’s outstanding equity securities are subject to the same restrictions) without the prior written consent of the Company or such underwriters for such period of time (not to exceed 180 days, which period may be
extended upon the request of the managing underwriter for an additional period of up to 15 days if the Company issues or proposes to issue an earnings or other public release within 15 days of the expiration of the 180 day lock-up period) from the
effective date of such registration and to execute an agreement as may be reasonably requested by the Company or the underwriters in connection with such registration and to use its commercially reasonable efforts to provide, within five business
days of a request, such information as may be required by the Company or the underwriters in connection with the completion of the initial public offering of the Company’s securities. 

9. Tax Consequences. Purchaser should obtain advice from an appropriate independent professional adviser with respect to
the taxation implications of the grant, issuance, purchase, retention, assignment, release, cancellation, sale or any other disposal of the Shares (each, a “Trigger Event”). Purchaser should also take advice in respect of the
taxation indemnity provisions under Section 10 below. 
 10. Purchaser’s Taxation Indemnity. 

(a) To the extent permitted by law, Purchaser hereby agrees to indemnify and keep indemnified the Company and the Company as trustee for
and on behalf of any affiliate entity, in respect of any liability or obligation of the Company and/or any affiliate entity to account for income tax or any other taxation provisions under the laws of Purchaser’s country of citizenship and/or
residence to the extent arising from a Trigger Event. 
 (b) The Company shall not be obliged to allot and issue any of the
Shares or any interest in the Shares unless and until Purchaser has paid to the Company such sum as is, in the opinion of the Company, sufficient to indemnify the Company in full against any liability the Company has for any amount of, or
representing, income tax or any other tax arising from a Trigger Event (the “Shares Tax Liability”), or Purchaser has made such other arrangement as in 

  
 13 

			
	Sunshine Silver Mines Corporation Long Term Incentive Plan	  	NQSO Agreement

  

 
the opinion of the Company will ensure that the full amount of any Shares Tax Liability will be recovered from Purchaser within such period as the Company may then determine. 

11. Data Protection. 
 (a) To facilitate the administration of the Plan and this Agreement, it will be necessary for the Company (or its payroll administrators) to collect, hold and process certain personal information about
Purchaser and to transfer this data to certain third parties such as brokers with whom Purchaser may elect to deposit any share capital under the Plan. Purchaser consents to the Company (or its payroll administrators) collecting, holding and
processing Purchaser’s personal data and transferring this data to the Company or any other third parties insofar as is reasonably necessary to implement, administer and manage the Plan. 

(b) Purchaser understands that Purchaser may, at any time, view Purchaser’s personal data, require any necessary corrections to it
or withdraw the consents herein in writing by contacting the Company, but acknowledges that without the use of such data it may not be practicable for the Company to administer Purchaser’s involvement in the Plan in a timely fashion or at all
and this may be detrimental to Purchaser. 
 12. Miscellaneous. 

(a) Governing Law. This Agreement and all acts and transactions pursuant hereto and the rights and obligations of the
parties hereto shall be governed by and construed in accordance with the Laws of the State of New York (including Section 5-1401 of the General Obligations Law of the State of New York but otherwise without regard to conflicts of Laws
principles). 
 (b) Dispute Resolution and Arbitration. The Company and Purchaser shall attempt in good faith to
resolve any dispute arising out of or relating to this Agreement promptly by negotiation. If the matter has not been resolved within thirty (30) calendar days of a party’s request for negotiation, either party may initiate proceedings or
arbitration only as provided herein. If any dispute arising out of or relating to this Agreement or the breach, termination or validity thereof has not been resolved by negotiation, such dispute shall be settled by binding arbitration in accordance
with the then current rules of JAMS by a single independent and impartial arbitrator who is located in Denver, Colorado. The arbitrator selected must have an expertise in the matter(s) in dispute. Each party shall bear his/its own fees and costs;
the fees, costs and all administrative expenses of arbitration shall be borne equally by the Company and Purchaser. The parties understand and agree that the arbitration is subject to the rules of JAMS; that the arbitrator’s decision and award
shall be final and binding as to all claims that were, or could have been, raised in arbitration; and that judgment upon the award rendered by the arbitrator may be entered in any court having competent jurisdiction. Any award rendered hereunder may
include an award of attorneys’ fees and costs but shall not include punitive damages. The statute of limitations of the state of New York applicable to the commencement of a lawsuit shall apply to the commencement of an arbitration. 

(c) Entire Agreement; Enforcement of Rights. This Agreement, the Option Agreement and the Plan set forth the entire
agreement and understanding of the parties relating 

  
 14 

			
	Sunshine Silver Mines Corporation Long Term Incentive Plan	  	NQSO Agreement

  

 
to the subject matter herein and merges all prior discussions between them. No modification of or amendment to this Agreement, nor any waiver of any rights under this Agreement, shall be
effective unless in writing signed by the parties to this Agreement. The failure by either party to enforce any rights under this Agreement shall not be construed as a waiver of any rights of such party. 

(d) Severability. If one or more provisions of this Agreement are held to be unenforceable under applicable law, the parties agree
to renegotiate such provision in good faith. In the event that the parties cannot reach a mutually agreeable and enforceable replacement for such provision, then (i) such provision shall be excluded from this Agreement, (ii) the balance of
the Agreement shall be interpreted as if such provision were so excluded and (iii) the balance of the Agreement shall be enforceable in accordance with its terms. 
 (e) Construction. This Agreement is the result of negotiations between and has been reviewed by each of the parties hereto and their respective counsel, if any; accordingly, this Agreement
shall be deemed to be the product of all of the parties hereto, and no ambiguity shall be construed in favor of or against any one of the parties hereto. 
 (f) Notices. Any notice provided for in this Agreement shall be in writing and shall be either personally delivered, sent by reputable overnight courier service or mailed by first class
mail, return receipt requested, to the recipient at the address below indicated: 
 Notices to Purchaser: 

Roger P. Johnson 

2422 Glenarm Place 
 Denver, Colorado 80205 
 Notices to the Company: 

Sunshine Silver Mines Corporation 
 c/o Tigris Financial Group Ltd. 
 535 Madison Avenue, 11th Floor 

New York, New York 10022 
 Attention:   Andrew M. Shapiro, Esq. 
 or such other address or to
the attention of such other person as the recipient party shall have specified by prior written notice to the sending party. Any notice under this Agreement shall be deemed to have been given when so delivered, sent or mailed. 

(g) Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original and
all of which together shall constitute one instrument. 
 (h) Successors and Assigns. The rights and benefits of
this Agreement shall inure to the benefit of, and be enforceable by the Company’s successors and assigns. The rights and obligations of Purchaser under this Agreement may only be assigned with the prior written consent of the Company.

  
 15 

			
	Sunshine Silver Mines Corporation Long Term Incentive Plan	  	NQSO Agreement

  

 [Signature Page Follows] 

  
 16 

			
	Sunshine Silver Mines Corporation Long Term Incentive Plan	  	NQSO Agreement

  

 The parties have executed this Exercise Notice and Restricted Stock Purchase Agreement as of the date
first set forth above. 
  

			
	SUNSHINE SILVER MINES CORPORATION
		
	By:	 	  

		
	Name:	 	  

		
	Title:	 	  

			
	
	PURCHASER:
	
	(Signature)
	
	  

	(Printed Name)
		
	Address:	 	  

	
	  

 I,
                        , spouse of «Optionee», have read and hereby approve the foregoing Agreement. In
consideration of the Company’s granting my spouse the right to purchase the Shares as set forth in the Agreement, I hereby agree to be irrevocably bound by the Agreement and further agree that any community property or other such interest shall
hereby be similarly bound by the Agreement. I hereby appoint my spouse as my attorney-in-fact with respect to any amendment or exercise of any rights under the Agreement. 

 

	
	  

	Spouse of «Optionee»

  
 17 

			
	Sunshine Silver Mines Corporation Long Term Incentive Plan	  	NQSO Agreement

  

 Annex 1 

QUESTIONNAIRE2 
 The undersigned represents and warrants that it comes within each category marked below, and that for any category marked, it has truthfully set forth the factual basis or reason the undersigned comes
within that category. The undersigned agrees to furnish any additional information which Sunshine Silver Mines Corporation (the “Company”) deems necessary in order to verify the answers set forth below. 

 

					
	  ̈
	  	(a)	  	The undersigned is an individual (not a partnership, corporation, etc.) whose individual net worth, or joint net worth with its spouse, presently exceeds
$1,000,000.
			
		  		  	Explanation. In calculating net worth you may include equity in personal property and real estate (other than your primary residence) cash, short-term investments, stock and
securities. Equity in personal property and real estate should be based on the fair market value of such property less debt secured by such property. You must exclude from the calculation the value of your primary residence, and the related amount
of indebtedness up to the fair market value of the residence may also be excluded. Indebtedness secured by the residence in excess of its fair market value must be deducted from your net worth.
			
	  ̈
	  	(b)	  	The undersigned is an individual (not a partnership, corporation, etc.) who had an income in excess of $200,000 in each of the two most recent years, or joint income with their
spouse in excess of $300,000 in each of those years (in each case including foreign income, tax exempt income and full amount of capital gains and loses but excluding any income of other family members and any unrealized capital appreciation) and
has a reasonable expectation of reaching the same income level in the current year.
			
	  ̈
	  	(c)	  	The undersigned is a director or executive officer of the Company, which is issuing the Shares.
			
	  ̈
	  	(d)	  	The undersigned is not within any of the categories above and is therefore a nonaccredited investor.

 THE UNDERSIGNED IS INFORMED OF THE SIGNIFICANCE TO THE COMPANY OF THE FOREGOING REPRESENTATIONS, AND THEY ARE MADE WITH
THE INTENTION THAT THE COMPANY WILL RELY ON THEM. 
 IN WITNESS WHEREOF, the undersigned has executed the Questionnaire on
                    ,             . 

 
  

	2 	 Include only for Regulation D awards. 

  
 18 

			
	Sunshine Silver Mines Corporation Long Term Incentive Plan	  	NQSO Agreement

  

  

	
	  

	(Signature)

  
 19Employment Agreement

 Exhibit 10.1 
 EMPLOYMENT AGREEMENT 
 THIS EMPLOYMENT AGREEMENT (this
“Agreement”) is made and entered into by and between MEDNAX SERVICES, INC., a Florida corporation (“Employer”), and ROGER J. MEDEL, M.D. (“Employee”) effective as of the 7th day of August, 2011 (the
“Effective Date”). 
 RECITALS 
 WHEREAS, Employer is presently engaged in “Employer’s Business” as defined on Exhibit A hereto; 
 WHEREAS, Employee is a founder of Employer and currently serves as Chief Executive Officer of Employer pursuant to an Employment Agreement effective as of August 20, 2008 (the “Prior
Employment Agreement”); 
 WHEREAS, Employer and Employee desire to replace the Prior Employment Agreement with this
Agreement effective as stated above and set forth herein the terms and conditions of Employee’s employment with Employer following termination of the Prior Employment Agreement; and 

WHEREAS, in order to induce Employee to enter into this Agreement on the terms and conditions set forth herein (including an
increase in compensation over what was provided under the Prior Employment Agreement), and not disclose its trade secrets and Confidential Information in connection with Employee’s employment by Employer and provide incentive compensation
during the term of this Agreement, Employee hereby agrees to be bound by the terms of this Agreement, including the arbitration, non-competition and related restrictive covenants set forth herein. 

 NOW, THEREFORE, in consideration of the premises and mutual covenants set forth
herein, the parties agree as follows: 
 1. Employment. 

1.1. Employment and Term. Employer hereby agrees to employ Employee and Employee hereby agrees to serve Employer on
the terms and conditions set forth herein for a “Term” that commences on the Effective Date and continues for a period of seven (7) years through August 7, 2018, unless sooner terminated in accordance with the provisions of
Section 4. In this Agreement, the term “Employment Period” shall refer to the period of time beginning on the Effective Date and ending on the earlier of the expiration of the Term or such earlier date as the employment of Employee is
terminated pursuant to the provisions of Section 4 of this Agreement. Employer and Employee agree that the Prior Employment Agreement shall terminate and be of no further force and effect as of the Effective Date. 

1.2. Duties of Employee. During the Employment Period, Employee shall serve as Chief Executive Officer of Employer
and of Mednax, Inc., a Florida corporation and parent corporation of Employer (“Mednax”), and perform such duties as are customary to the positions Employee holds or as may be reasonably assigned to Employee during the term of this
Agreement by the Board of Directors of Mednax (“Employee’s Supervisor” or the “Mednax Board”) provided, that such duties as assigned shall be customary to Employee’s role as an executive officer of Employer and
Mednax. Employee’s employment shall be full-time and as such Employee agrees to devote substantially all of Employee’s 

  
 2 

 
attention and professional time to the business and affairs of Employer and Mednax. During the Employment Period, Employer shall promote the proficiency of Employee by, among other things,
providing Employee with Confidential Information, specialized professional development programs, and information regarding the organization, administration and operation of Employer and Mednax. During the Employment Period, Employee agrees that
Employee will not, without the prior written consent of Mednax (which consent shall not be unreasonably withheld), serve as a director on a corporate board of directors or in any other similar capacity for any institution other than Mednax. Employee
may continue to serve as a director on any corporate board of directors on which he serves as of the Effective Date, and he may continue to serve in any other similar capacity in which he serves as of the Effective Date for any institution. During
the Employment Period, it shall not be a violation of this Agreement to (i) serve on other civic or charitable boards or committees, or (ii) deliver lectures, fulfill speaking engagements or teach at educational institutions, so long as
such activities do not interfere with the performance of Employee’s responsibilities as an employee of Employer and Mednax in accordance with this Agreement, including the restrictions of Section 8 hereof. 

1.3. Place of Performance. Employee shall be based at Employer’s offices located in Sunrise, Florida,
except for required travel relating to Employer’s Business. 
 2. Base Salary and Performance Bonus.

 2.1. Base Salary. Employee shall be paid an annual base salary of $1,000,000.00 (the “Base
Salary”) beginning August 7, 2011 and continuing during the Employment Period, payable in installments consistent with Employer’s customary payroll schedule and subject to applicable withholding for taxes and Employee directed
withholdings. The Compensation Committee of the 

  
 3 

 
Mednax Board (the “Compensation Committee”) shall review the amount of Employee’s Base Salary on an annual basis no later than ninety (90) days after the beginning of
Employer’s fiscal year. During the term of the Agreement, the Compensation Committee may approve increases to Employee’s Base Salary, which will then become the Base Salary for purposes of this Agreement. 

2.2. Performance Bonus. During the Employment Period, Employee shall be eligible for an annual bonus (the
“Performance Bonus”) in accordance with incentive programs approved or revised during the term of this Agreement by the Compensation Committee, which programs shall contemplate a target bonus payment of at least One Hundred Fifty Percent
(150%) up to a maximum bonus opportunity of Three Hundred Percent (300%) of Employee’s Base Salary upon the fulfillment of reasonable performance objectives set by the Compensation Committee. The Compensation Committee may adjust the
target and maximum bonus at its discretion during the term of this Agreement but not below the levels set forth in the preceding sentence. Each Performance Bonus shall be paid in the calendar year immediately following the calendar year in which it
is earned as soon as practicable after the audited financial statements for Employer for the year for which the bonus is earned have been released; provided, however, that if calculation of Employee’s Performance Bonus within such time is not
administratively practicable due to events beyond the control of Employer, then Employer may delay payment of the Performance Bonus provided that the payment is made during the first taxable year of Employee in which the calculation of the amount of
the payment is administratively practicable. 
 3. Benefits. 

3.1. Expense Reimbursement. Employer shall promptly reimburse Employee for all out-of-pocket expenses reasonably
incurred by Employee during the Employment Period on behalf of or in connection with Employer’s 

  
 4 

 
Business pursuant to the reimbursement standards and guidelines of Employer in effect or changed during the term of this Agreement. Employee shall account for such expenses and submit reasonable
supporting documentation to Employer in accordance with Employer’s policies in effect during the term of this Agreement. 
 3.2. Employee Benefits. During the Employment Period, Employee shall be entitled to participate in such health, welfare, disability, stock purchase, retirement savings and other fringe benefit
plans and programs as may be established and maintained by Employer, including any changes to such benefits, to the extent that such plans and programs are applicable to other similarly situated employees of Employer and subject to the provisions of
such plans and programs. 
 3.3. Leave Time. During the Employment Period, Employer shall allow Employee
thirty eight (38) days of paid time off each year for vacation, illness, injury, personal days or other similar purposes in accordance with Employer’s policies in effect or revised during the term of this Agreement (prorated for periods of
less than a calendar year). Any paid time off not used during each calendar year may be carried over into the next year to the extent permitted by Employer’s policies in effect or revised during the term of this Agreement. 

3.4. Incentive Compensation Plan. During the Employment Period, Employee shall be eligible to
participate in Mednax’s incentive compensation plans that provide for the issuance of stock options, restricted stock and other awards to its employees. Employee’s stock based award each year shall be determined by the Compensation
Committee based on Employee’s performance and Mednax’s performance during the immediately preceding year and shall be consistent with the Compensation Committee’s determination of Employee’s stock based award in prior years. The
terms of any award to Employee and Employee’s rights and interest in any such award shall be controlled by this 

  
 5 

 
Agreement, the award agreement and appropriate incentive compensation plans. Employee acknowledges that this Section 3 is sufficient consideration for Employee to enter into this agreement,
including the restrictive covenants set forth in Section 8 below. 
 3.5. Personal Use of Corporate
Aircraft. Corporate aircraft, whether outright or leased by Mednax (including any subsidiary of Mednax), jointly with another person or entity, or by fractional interest, may be used by Employee during the Employment Period for personal matters;
provided, however, (i) the aircraft is not being used, nor during the period Employee has requested use for personal matters will it be needed for use, by Employer for business-related matters, as Employer shall have priority over
Employee’s personal use; and (ii) Employee’s personal use of the aircraft does not exceed a total of ninety-five (95) hours of flight in any calendar year without the advance approval of the Compensation Committee. Such personal
use of the aircraft by Employee shall be treated as imputed income to Employee in accordance with rules and regulations of the Internal Revenue Code of 1986, as amended. 

3.6. Legal Fees. Employer shall reimburse Employee for the reasonable legal fees and expenses incurred by Employee
in connection with the review and negotiation of this Agreement and the related Restricted Shares Units Agreement. Employer shall also reimburse Employee for all reasonable legal fees and expenses that Employee may incur in connection with
performance of his duties during the Term of this Agreement. All reimbursements described in this paragraph shall be made promptly after demand is made by Employee and Employee’s provision to the Employer of reasonably satisfactory evidence of
such fees and expenses, but no later than the last day of the calendar year following the calendar year in which Employee incurs such fees and expenses. 

  
 6 

 4. Termination. 

4.1. Termination for Cause. Employer may terminate Employee’s employment under this Agreement for Cause. As
used in this Agreement, the term “Cause” shall mean the occurrence of any of (i) Employee’s engagement in (A) willful misconduct resulting in material harm to Mednax. or Employer, or (B) gross negligence;
(ii) Employee’s conviction of, or pleading nolo contendere to, a felony or any other crime involving fraud, financial misconduct, or misappropriation of Employer’s assets; (iii) Employee’s willful and continual failure,
after written notice from Employee’s Supervisor to (A) perform substantially his employment duties consistent with his position and authority, or (B) follow, consistent with Employee’s position, duties, and authorities, the
reasonable lawful mandates of Employee’s Supervisor; or (iv) Employee’s breach of Section 8 of this Agreement. No act or omission shall be deemed willful or grossly negligent for purposes of this definition if taken or omitted to
be taken by Employee in a good faith belief that such act or omission to act was in the best interests of the Employer or Mednax or if done at the express direction of the Mednax Board. The termination date for a termination of
Employee’s employment under this Agreement pursuant to this Section 4.1 shall be the date specified by Employer in a written notice to Employee of finding of Cause, which may not be retroactive. Upon termination of Employee’s
employment under this Agreement pursuant to Section 4.1, Employee shall be entitled to compensation in accordance with and subject to, the provisions of Section 5.1 hereof. 

4.2. Disability. Upon the Disability (as defined below) of Employee, Employee shall be entitled to compensation
and/or benefits in accordance with, and subject to, the provisions of Section 5.2 hereof. In addition, Employee’s employment under this Agreement shall terminate automatically upon the Disability of Employee. Notwithstanding the automatic
termination of Employee’s employment under the preceding sentence, benefits under this Section 4.2 shall be based on Employee’s Disability, and not on Employee’s 

  
 7 

 
termination, and Employee shall not be entitled to any termination benefits under this Agreement. Subject to the requirements of applicable law, Employee shall be deemed to have a
“Disability” for purposes of this Agreement in the event that Employee (i) is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which can be expected to result
in death or can be expected to last for a continuous period of not less than twelve (12) months, or (ii) is, by reason of any medically determinable physical or mental impairment which can be expected to result in death or can be expected
to last for a continuous period of not less than twelve (12) months, receiving income replacement benefits for a period of not less than three (3) months under an accident and health plan covering employees of Employer. 

4.3. Death. Employee’s employment under this Agreement shall terminate automatically upon the death of
Employee, without any requirement of notice by Employer to Employee’s estate. The date of Employee’s death shall be the termination date of Employee’s employment under this Agreement pursuant to this Section 4.3. Upon any
termination of Employee’s employment under this Agreement pursuant to this Section 4.3, Employee shall be entitled to the compensation specified in Section 5.3 hereof. 

4.4. Termination by Employer Without Cause. Employer may terminate Employee’s employment without Cause by
giving Employee written notice of such termination. The termination date shall be the date specified by Employer in such notice, which shall not be less than ninety (90) days from the date of written notice to Employee. Upon any termination of
Employee’s employment under this Agreement pursuant to this Section 4.4, Employee shall be entitled to compensation and/or benefits in accordance with, and subject to, the provisions of Section 5.4 hereof. 

  
 8 

 4.5. Termination by Employee Due to Poor Health. Employee may
terminate Employee’s employment under this Agreement upon written notice to Employer if Employee’s health should become impaired to any extent that makes the continued performance of Employee’s duties under this Agreement hazardous to
Employee’s physical or mental health or Employee’s life (regardless of whether such condition would be deemed a Disability under any other Section of this Agreement), provided that Employee shall have furnished Employer with a
written statement from a qualified doctor to that effect, and provided further that, at Employer’s written request and expense, Employee shall submit to a medical examination by an independent qualified physician selected by Employer and
acceptable to Employee (which acceptance shall not be unreasonably withheld), which doctor shall substantially concur with the conclusions of Employee’s doctor. The termination date shall be ninety (90) days from Employer’s receipt of
such notice. Upon any termination of Employee’s employment under this Agreement pursuant to this Section 4.5, Employee shall be entitled to compensation and/or benefits in accordance with, and subject to, the provisions of Section 5.5
hereof. 
 4.6. Termination by Employee. Employee may terminate Employee’s employment under this
Agreement for any reason whatsoever upon not less than ninety (90) days prior written notice to Employer. Upon receipt of such notice from Employee, Employer may, at its option, require Employee to terminate employment at any time in advance of
the expiration of such ninety (90) day period. The termination date under this Section 4.6 shall be the date specified by Employer, but in no event more than ninety (90) days after Employer’s receipt of notice from Employee as
contemplated by this Section 4.6. Upon any termination of Employee’s employment under this Agreement pursuant to this Section 4.6, Employee shall be entitled to compensation and/or benefits in accordance with, and subject to, the
provisions of Section 5.6 hereof. 

  
 9 

 4.7. Termination by Employee for Good Reason. Employee may terminate
Employee’s employment under this Agreement for Good Reason. For purposes of this Section, “Good Reason” shall mean the occurrence of any of the following: 

(a) a material diminution in the Employee’s Base Salary or Performance Bonus eligibility; 

(b) a material diminution in the Employee’s authority, duties, or responsibilities; 

(c) a material diminution in the authority, duties or responsibilities of the supervisor to whom the Employee is required
to report, including a requirement that the Employee report to a corporate officer or employee instead of reporting directly to the Mednax Board; 
 (d) a material diminution in the budget over which the Employee retains authority; 
 (e) a material change in the geographic location at which the Employee must perform the services under this Agreement; or 

(f) any other action or inaction that constitutes a material breach by the Employer under this Agreement. 

For purposes hereof, “Good Reason” shall not be deemed to exist unless the Employee provides the Employer with written notice of
the existence of such condition within ninety (90) days after the initial existence of the condition and the Employer fails to remedy the condition within thirty (30) days after its receipt of such notice. 

  
 10 

 Notice of the condition shall include the proposed termination date of Employee’s
employment under this Agreement, which must be ninety (90) days from the date of the notice. If Employer fails to remedy the condition, Employer may, at its option, require Employee to terminate employment at any time in advance of the
expiration of such ninety (90) day period. The termination date under this Section 4.7 shall be the date specified by Employer, but in no event more than ninety (90) days after Employer’s receipt of notice from Employee as
contemplated by this Section 4.7. If Employee terminates Employee’s employment under this Agreement pursuant to this Section 4.7, then Employee shall be entitled to compensation and/or benefits in accordance with, and subject to, the
provisions of Section 5.7 hereof. 
 4.8. Termination of Employee in Connection With Change in Control of
Employer. In the event that Employer terminates Employee’s employment without Cause in accordance with Section 4.4, or Employee terminates Employee’s employment for Good Reason in accordance with Section 4.7, and in either
case the termination occurs within twenty four (24) months following a Change of Control of Mednax (as defined below), then in lieu of the compensation and/or benefits that Employee would otherwise be entitled to under Section 5.4 or
Section 5.7, Employee shall be entitled to the compensation and/or benefits in accordance with, and subject to, the provisions of Section 5.8. For purposes of this Agreement, “Change in Control” of Mednax shall mean (i) the
acquisition by a person or an entity or a group of persons and entities, directly or indirectly, of more than fifty (50%) percent of Mednax common stock in a single transaction or a series of transactions (hereinafter referred to as a “50%
Change in Control”); (ii) a merger or other form of corporate reorganization of Mednax resulting in an actual or de facto 50% Change in 

  
 11 

 
Control; or (iii) the failure of Applicable Directors (defined below) to constitute a majority of the Mednax Board during any two (2) consecutive year period commencing on or after
January 1, 2012 (the “Two-Year Period”). “Applicable Directors” shall mean those individuals who are members of the Board at the inception of a Two-Year Period and any new director whose election to the Board or nomination
for election to the Board was approved (prior to any vote thereon by the shareholders) by a vote of at least two-thirds (2/3) of the directors then still in office who either were directors at the beginning of the Two-Year Period at issue or
whose election or nomination for election during such Two-Year Period was previously approved as provided in this sentence.
 5. Compensation and Benefits Upon Termination or Disability. 

5.1. Cause. If Employee’s employment is terminated for Cause, Employer shall pay Employee’s Base Salary
through the termination date specified in Section 4.1 at the rate in effect at the termination date. Upon payment of such amount, plus any amounts as may be due under Section 5.10 below, Employer shall have no further obligation to
Employee under this Agreement, other than any benefits to which Employee is entitled under Section 5.13 below. 
 5.2. Disability. In the event of Employee’s Disability, Employer shall continue to pay Employee’s monthly Base Salary for a period of twelve (12) months following the date of
Employee’s Disability, plus any amount due under Sections 5.10 and 5.11 hereof. Amounts payable under this Section 5.2 are not intended to be in lieu of benefits under any long-term disability plan. Employer may maintain and
revise during the term of this Agreement, and Employee’s entitlement to benefits under such plan, if any, shall be determined solely by the plan’s terms. 

  
 12 

 5.3. Death. Upon Employee’s death during the Employment Period,
Employer shall pay to the person or entity designated by Employee in a notice filed with Employer or, if no person is designated, to Employee’s estate any unpaid amounts of Base Salary to the date of Employee’s death, plus any amounts as
may be due under Sections 5.10 and 5.11 below. Any payments Employee’s spouse, beneficiaries or estate may be entitled to receive pursuant to any pension plan, employee welfare benefit plan, life insurance policy, or similar plan or policy then
maintained by Employer shall be determined and paid in accordance with the written instruments governing the respective plans and policies. In the event of Employee’s death during the Employment Period, Employer shall notify Employee’s
designee or estate of the stock awards held by Employee and the procedures pursuant to which all vested stock options may be exercised and other stock awards may be realized under the terms applicable to such awards. 

5.4. Termination by Employer Without Cause. If Employer terminates Employee’s employment in accordance with
Section 4.4, then Employer shall pay Employee’s Base Salary through the termination date specified in Section 4.4 at the rate in effect at such termination date, plus any amount due under Sections 5.10 and 5.11 hereof. In
addition, Employee will continue to receive the same Base Salary payment in effect on such termination date for a period of twenty four (24) months following termination date under the same conditions, less normal and standard deductions under
federal and state laws. Employee will also receive on the first and second anniversaries of such termination date a payment equal to the greater of: 
 (a) Employee’s most recent performance bonus paid prior to such termination date, or 

  
 13 

 (b) The average of his earned performance bonus (expressed as a percentage
of Base Salary) for the previous three years preceding such termination date, multiplied by his Base Salary at time of termination 
 5.5. Termination by Employee Due to Poor Health. If Employee terminates employment under this Agreement pursuant to Section 4.5 hereof, Employer shall pay to Employee any unpaid amounts of
Base Salary to the termination date specified in Section 4.5, plus any disability payments otherwise payable by or pursuant to plans provided by Employer, plus any amounts as may be due under Section 5.10 and 5.11 hereof. 

5.6. Termination by Employee. If Employee’s employment under this Agreement terminates pursuant to
Section 4.6 hereof, Employer shall pay to Employee any unpaid amounts of Base Salary to the termination date specified in Section 4.6, plus any amounts as may be due under Section 5.10 and 5.11 below. In the event that the termination
date specified by Employer is less than ninety (90) days after the date of Employer’s receipt of notice as contemplated by Section 4.6, then Employer shall continue Employee’s Base Salary for a period of days equal to ninety
(90) minus the number of days from Employee’s notice to the termination date. 
 In addition, if
Employee gives Employer sufficient notice in accordance with Section 4.6 and executes, and does not revoke, a general release of claims pursuant to Section 5.18 of this Agreement, Employer shall pay Employee a bonus calculated in
accordance with Section 5.11 hereof. 
 5.7. Termination by Employee for Good Reason. If
Employee’s employment under this Agreement is terminated in accordance with Section 4.7, then Employer shall pay Employee’s Base Salary through the termination date 

  
 14 

 
specified pursuant to Section 4.7 at the rate in effect at such termination date, plus any amounts as may be due under Sections 5.10 and 5.11 hereof. In addition, Employee will continue
to receive the same Base Salary payment in effect on such termination date for a period of twenty four (24) months following termination date under the same conditions, less normal and standard deductions under federal and state laws. Employee
will also receive on the first and second anniversaries of such termination date a payment equal to the greater of: 
 (a) Employee’s most recent performance bonus paid prior to such termination date, or 
 (b) The average of his earned performance bonus (expressed as a percentage of Base Salary) for the previous three years preceding such termination date, multiplied by his Base Salary at time of
termination 
 5.8. Termination of Employee in Connection With Change in Control of Employer. If
Employee’s employment under this Agreement is terminated in accordance with Section 4.8, then Employer shall pay Employee’s Base Salary through the termination date specified pursuant to Section 4.8 at the rate in effect at such
termination date, plus any amounts as may be due under Section 5.10 hereof. In addition, Employee will receive the following severance payments from Employer: 

(a) Continuation of the same Base Salary in effect at such termination date for a period of thirty six (36) months
with payments under the same conditions, less normal and standard deductions under federal and state laws. 
 (b)
Within 90 days following such termination date, Employee will receive a lump sum payment in an amount equal to three times the greater of (1)

  
 15 

 
his most recent performance bonus paid prior to such termination date, or (2) the average of his earned performance bonus (expressed as a percentage of Base Salary) for the three years
preceding such termination date, multiplied by his Base Salary at time of termination. 
 5.9. Reduction of
Parachute Payments. 
 (a) Anything in this Agreement to the contrary notwithstanding, in the event it
shall be determined that any payment or distribution by Employer to or for the benefit of Employee (whether paid or payable or distributed or distributable pursuant to the terms of this Agreement or otherwise) (a “Payment”) would
(i) constitute a “parachute payment” within the meaning of Section 280G of the Internal Revenue Code of 1986, as amended, and (ii) be subject to the excise tax imposed by Section 4999 of the Code, or any successor
provisions thereto, including any corresponding provision of any subsequent Internal Revenue Code, as the same may be amended from time to time, (the “Excise Tax”), then such Payment shall be reduced to the Reduced Amount (as
defined below). 
 (b) The “Reduced Amount” shall be the largest portion of the Payment that would
result in no portion of the Payment being subject to the Excise Tax; provided, however, if the entire Payment, after taking into account all applicable federal, state and local employment taxes, income taxes, and the Excise Tax (all computed at the
highest applicable marginal rate), results in Employee’s receipt, on an after-tax basis, of an amount greater than the Reduced Amount, then Employee shall receive the entire Payment in lieu of the Reduced Amount. If a reduction in payments or
benefits constituting “parachute payments” is necessary so that the Payment equals the Reduced Amount, unless otherwise determined by Employer no later than two (2) days prior to the termination date set forth in the notice of
termination given pursuant to Section 4.4 or Section 

  
 16 

 
4.7, as applicable, the reduction shall occur in the manner that results in the greatest economic benefit to Employee as determined in this paragraph. If more than one method of reduction will
result in the same economic benefit, the portions of the Payment shall be reduced pro rata. 
 (c) All
determinations required to be made under this Section 5.9, including whether a Payment shall be reduced to the Reduced Amount, and the assumptions to be utilized in arriving at such determination, shall be made by a “Big Four”
accounting firm (the “Accounting Firm”) or other qualified professional firm as selected and agreed to by Employee and the Mednax Board of Directors; provided, that the Accounting Firm shall not also be Mednax’s independent
auditor. The Employer shall bear all expenses with respect to the determinations by the Accounting Firm required to be made hereunder. 
 (d) The Accounting Firm shall provide its calculations, together with detailed supporting documentation, to Employer and Employee within fifteen (15) business days after the date on which
Employee’s right to a Payment is triggered (if requested at that time by Employer or Employee) or such other time as requested by Employer or Employee. If the Accounting Firm determines that no Excise Tax is payable with respect to a Payment,
either before or after the application of the Reduced Amount, it shall furnish Employer and Employee with an opinion reasonably acceptable to Employer and Employee that no Excise Tax will be imposed with respect to such Payment. Any good faith
determinations of the Accounting Firm made hereunder shall be final, binding and conclusive upon Employer and Employee. 
 5.10. Expense Reimbursement. Employee shall be entitled to reimbursement for reasonable business expenses incurred prior to the termination date, subject, however to the provisions of
Section 3.1. Such reimbursement shall be made at the times and in accordance with Employer’s normal procedures for reimbursements. 

  
 17 

 5.11. Performance Bonus. In the situations described in Sections 5.2,
5.3, 5.4, 5.5, 5.6 and 5.7 upon termination of Employee’s employment under this Agreement, Employee shall be paid a bonus with respect to Employer’s fiscal year in which the termination date occurs, equal to the Performance Bonus, if any,
that would have been payable to Employee for the fiscal year if Employee’s employment had not been terminated, multiplied by the number of days in the fiscal year prior to and including the date of termination and divided by three hundred
sixty-five (365). Any amount payable under this Section 5.11 shall be paid to Employee when Employer pays performance bonuses to its eligible employees, which shall be in the calendar year following the termination date of this Agreement.

 5.12. Employment Transition and Severance Agreement. If Employer so requests within five business days
following a termination of Employee’s employment under this Agreement pursuant to Section 4.2, 4.4, 4.5, or 4.7, Employee shall continue to be employed by Employer on a part time basis for a period (the “Transition Period”) to be
determined by Employer that shall not exceed ninety (90) days, unless extended by mutual agreement. During the Transition Period, Employee shall perform (to the extent reasonably capable in the case of a termination pursuant to Section 4.2
or Section 4.5) such services as may reasonably be required for the transition to others of matters previously within Employee’s responsibilities. Unless otherwise mutually agreed, Employee will not be required to serve more than five
(5) days per month during the Transition Period. For services during the Transition Period, Employee shall be compensated at a daily rate equal to his Base Salary immediately preceding the termination of this Agreement divided by 365.

  
 18 

 5.13. Continuation of Group Health Coverage. 

(a) Extended Coverage in the Event of Reduction of Employee’s Hours of Employment. In the event that a reduction of
hours of Employee’s employment would otherwise cause a loss of group health coverage as an employee and such loss would entitle Employee and his eligible dependents to elect health care continuation coverage under Section 601 et
seq. of the Employee Retirement Income Security Act of 1974, 29 U.S.C. § 1161, et seq. (“COBRA”), Employee and his eligible dependents will be entitled to the following. Except as provided in Section 5.13(d), or
5.13(e) below, Employee and his eligible dependents will be entitled to elect (for the duration of Employee’s employment by Employer) to continue to participate in any self-insured group health plan sponsored by Employer for its employees on
the same basis as regular, full-time employees of Employer and their eligible dependents. As a condition of eligibility to elect extended coverage of health care benefits under this Section 5.13(a), Employee and his eligible dependents must
first irrevocably decline any continuation coverage provided pursuant to COBRA. Employee and each of his eligible dependents shall have an independent opportunity to decline COBRA coverage in favor of extended coverage under this
Section 5.12(a), and the election or nonelection by Employee and/or any of his eligible dependents shall not effect the eligibility of the others to elect coverage under this Section 5.13(a). 

(b) Transition Periods. Except as provided in Section 5.13(d) or 5.13(e) below, Employee and his eligible dependents
will be entitled, during any Transition Period, to continue to participate in any self-insured, group health plan sponsored by Employer for its employees on the same basis as regular, full-time employees of Employer and their eligible dependents.

  
 19 

 (c) Alternate Extended Coverage. Except as provided in Section 5.13(d)
or 5.13(e) below, upon Employee’s termination of employment for any reason, Employee (if living) and his eligible dependents will be entitled to elect (for a period of five (5) years following the later of the Employee’s termination
date or the end of the Transition Period) to continue to participate in any self-insured group health plan sponsored by Employer for its employees on the same basis as regular, full-time employees of Employer and their eligible dependents. As a
condition of eligibility to elect the alternate extended coverage of health care benefits under this Section 5.13(c), Employee and his eligible dependents must first irrevocably decline any continuation coverage provided pursuant to COBRA.
Employee and each of his eligible dependents shall have an independent opportunity to decline COBRA coverage in favor of the alternate extended coverage under this Section 5.13(c), and the election or nonelection by Employee and/or any of his
eligible dependents shall not affect the eligibility of the others to elect coverage under this Section 5.13(c). 
 (d) Payment for Coverage. Employee will pay the full cost of any continued group health coverage provided under Section 5.13(a), 5.13(b), or 5.13(c), which is understood to be equal to the
“applicable premium” as determined under Section 604 of the Employee Retirement Income Security Act of 1974, 29 U.S.C. § 1164. 
 (e) Employer Option to Provide Insurance. In its sole discretion, Employer may provide health care insurance to Employee and his eligible dependents through an insurance carrier(s) selected by Employer in
lieu of providing the coverage described in Section 5.13(a), 5.13(b), or 5.13(c) above, provided the coverage afforded by such insurance is substantially comparable to coverage under Section 5.13(a), 5.13(b), and 5.13(c) above.

  
 20 

 
Employee shall pay the cost of such insurance up to the amount that would have been paid by Employee under Section 5.13(d) above. Employer shall pay the excess cost, if any. 

(f) Indemnification for Income Tax. Employer and Employee do not contemplate that the provision of benefits under this
Section 5.13 will occasion any imputed income to Employee under Section 105(h) of the Internal Revenue Code of 1986, 26 U.S.C. § 105(h), for purposes of income taxes but, if it does, Employer agrees to indemnify Employee from and
against any income taxes imposed under Section 105(h) as a consequence of such imputed income. 
 5.14.
Vesting of Incentive Awards. Notwithstanding any contrary provision in this Agreement or any Stock Option or Incentive Compensation Plan then maintained by Mednax or Employer, (i) all stock options, stock appreciation rights, restricted
stock, and other stock-based awards granted to Employee by Mednax or Employer (as the predecessor to Mednax) prior to termination of this Agreement shall continue to vest until fully vested following a termination of Employee’s employment
pursuant to Section 4.2, 4.3, 4.4, 4.5, and 4.7, and (ii) in the event of a Change in Control of Mednax, all unvested stock options, stock appreciation rights, restricted stock, and other stock-based awards granted to Employee by Mednax or
Employer (as the predecessor to Mednax) shall automatically vest and, in the cases of stock options and stock appreciation rights, become immediately exercisable. This Section 5.14 shall not apply to the Restricted Share Units Agreements
entered into between Employee and Employer on August 20, 2008, and on August 7, 2011. 
 5.15.
Period for Exercising Stock Options After Termination. Except as to incentive stock options granted in accordance with Section 422 of the Internal Revenue Code, Employee shall be allowed a period of the greater of (i) twenty-four

  
 21 

 
(24) months after termination of Employee under this Agreement or (ii) twelve months from the applicable vesting date during which to exercise any vested options to purchase
Mednax’s common stock or vested stock appreciation rights and realize any other vested incentive compensation awards that may be granted or made under any equity compensation or incentive compensation plan or arrangement of Mednax (or the
Employer as the predecessor to Mednax); provided, however, that in no event shall the period during which Employee may exercise any vested stock option or vested stock appreciation right be extended pursuant to this Section 5.15 to a date that
is later than the earlier of (i) the latest date upon which the stock right could have expired by its original terms under any circumstances or (ii) the tenth anniversary of the original date of grant of the stock right. In all other
respects, the terms of the applicable equity compensation plan shall control the terms and conditions of any awards made pursuant thereto. 
 5.16. Assistant and Office. Upon Employee’s termination of employment for any reason, Employer will reimburse Employee for lease payments incurred by Employee in leasing an office in such
location as Employee and Employer shall mutually agree, and for reasonable wages paid by Employee to an administrative assistant, in each case on a continuing basis reasonably comparable to that provided to Employee currently, until the date that is
two (2) years from the date of termination. 
 5.17. Compliance with Section 409A.  

(a) General. It is the intention of both Employer and Employee that the benefits and rights to which Employee could be
entitled in connection with termination of employment comply with Section 409A of the Code and the Treasury Regulations and other guidance promulgated or issued thereunder (“Section 409A”), and the provisions of this Agreement shall
be construed in a manner consistent with that intention. If Employee or 

  
 22 

 
Employer believes, at any time, that any such benefit or right does not so comply, it shall promptly advise the other and shall negotiate reasonably and in good faith to amend the terms of such
benefits and rights such that they comply with Section 409A of the Code (with the most limited possible economic effect on Employee and on Employer). 
 (b) Distributions on Account of Separation from Service. If and to the extent required to comply with Section 409A, no payment or benefit required to be paid under this Agreement on account of
termination of Employee’s employment shall be made unless and until Employee incurs a “separation from service”, within the meaning of Section 409A. 

(c) 6-Month Delay for Specified Employees. 

(i) If Employee is a “specified employee”, then no payment or benefit that is payable on account of
Employee’s “separation from service”, as that term is defined for purposes of Section 409A, shall be made before the date that is six months after Employee’s “separation from service” (or, if earlier, the date of
Employee’s death) if and to the extent that such payment or benefit constitutes deferred compensation (or may be nonqualified deferred compensation) under Section 409A and such deferral is required to comply with the requirements of
Section 409A. Any payment or benefit delayed by reason of the prior sentence shall be paid out or provided in a single lump sum at the end of such required delay period in order to catch up to the original payment schedule. 

(ii) For purposes of this provision, Employee shall be considered to be a “specified employee” if, at the time
of his or her 

  
 23 

 
separation from service, Employee is a “key employee”, within the meaning of Section 416(i) of the Code, of Employer (or any person or entity with whom Employer would be considered
a single employer under Section 414(b) or Section 414(c) of the Code) any stock in which is publicly traded on an established securities market or otherwise. 

(iii) Unless otherwise required to comply with Section 409A, a payment or benefit shall not be deferred pursuant to
this provision if: 
 (x) it is not made on account of Employee’s “separation from service”,

 (y) it is required to be paid no later than within 2 1/2 months after the end of the taxable year of Employee in which the
payment or benefit is no longer subject to a “substantial risk of forfeiture”, as that term is defined for purposes of Section 409A, or 
 (z) the payment satisfies the following requirements: (A) it is being paid or provided due to Employer’s termination of Employee’s employment without Cause or Employee’s termination of
employment for Good Reason, (B) it does not exceed two times the lesser of (1) Employee’s annualized compensation from Employer for the calendar year prior to the calendar year in which the termination of Employee’s employment
occurs, and (2) the maximum amount of compensation that may be taken into account under a qualified 

  
 24 

 
plan pursuant to Section 401(a)(17) of the Code for the year in which Employee’s employment terminates, and (C) the payment is required under this Agreement to be paid no later
than the last day of the second calendar year following the calendar year in which Employee incurs a “separation from service. 
 (d) No Acceleration of Payments. Neither Employer nor Employee, individually or in combination, may accelerate any payment or benefit that is subject to Section 409A, except in compliance with
Section 409A and the provisions of this Agreement, and no amount shall be paid prior to the earliest date on which it may be paid without violating Section 409A. 

(e) Treatment of Each Installment as a Separate Payment. For purposes of applying the provisions of Section 409A to
this Agreement, each separately identified amount to which Employee is entitled under this Agreement shall be treated as a separate payment. In addition, to the extent permissible under Section 409A, any series of installment payments under
this Agreement shall be treated as a right to a series of separate payments. 
 (f) Reimbursements and In-Kind
Benefits. 
 (i) Any reimbursements by Employer to Employee of any eligible expenses pursuant to
Section 3.1 or 5.10 of this Agreement, that are not excludible from Employee’s income for Federal income tax purposes (“Taxable Reimbursements”) shall be made on or before the last day of the taxable year of Employee following
the year in which the expense was incurred. 

  
 25 

 (ii) The amount of any Taxable Reimbursements and the value of any in-kind
benefits to be provided to Employee under this Agreement during any taxable year of Employee shall not affect the expenses eligible for reimbursement, or in-kind benefits to be provided, in any other taxable year of Employee. 

(iii) The right to Taxable Reimbursements, or in-kind benefits, shall not be subject to liquidation or exchange for
another benefit. 
 5.18. Release. The Employer shall provide the Employee with a general release in the
form attached as Exhibit B (subject to such modifications as the Employer may reasonably request) within seven (7) days after the Employee’s termination date. Payments or benefits to which the Employee may be entitled pursuant to this
Article 5 (other than any accrued but unpaid Base Salary and employee benefits as of the end of the Employment Period) (the “Severance Amounts”) shall be conditioned upon the Employee executing the general release within 21 days after
receiving it from the Employer and the general release becoming irrevocable upon the expiration of 7 days following the Employee’s execution of it. Payment of the Severance Amounts shall be suspended during the period (the “Suspension
Period”) that begins on the Employee’s termination date and ends on the date (“Suspension Termination Date”) that is thirty-five (35) days after the Employee’s termination date; provided, however, that this suspension
shall not apply, and the Employer shall be required to provide, any continued health insurance coverage that would be required under Article 5.12 hereof during the Suspension Period. If the Employee executes the general release and the general
release becomes irrevocable by no later than the Suspension Termination Date, then payment of any Severance Amounts that were suspended pursuant to this provision shall be made in the first payroll period that follows the Suspension Termination
Date, and any Severance Amounts that are payable after the Suspension Termination Date shall be paid at the times provided in Article 5.

  
 26 

 6. Successors; Binding Agreement. 

6.1. Successors. Mednax shall require any successor (whether direct or indirect, by purchase, merger, consolidation
or otherwise) acquiring a majority of Mednax’s voting common stock or any other successor to all or substantially all of the business and/or assets of Mednax to expressly assume and agree to perform and cause Employer to perform this Agreement
in the same manner and to the same extent that Mednax or Employer would be required to perform it if no such succession had taken place and Employee hereby consents to any such assignment. This Section shall not limit Employee’s ability to
terminate his employment under this Agreement in the circumstances described in Section 4.8 in the event of a Change in Control of Mednax. 
 6.2. Benefit. This Agreement and all rights of Employee under this Agreement shall inure to the benefit of and be enforceable by Employee’s personal or legal representatives, executors,
administrators, successors, heirs, distributees, devisees and legatees. If Employee should die after the termination date and amounts would have been payable to Employee under this Agreement if Employee had continued to live, including under
Section 5 hereof, then such amounts shall be paid to Employee’s devisee, legatee, or other designee or, if there is no such designee, Employee’s estate. 

7. Conflicts with Prior Employment Contract. Except as otherwise provided in this Agreement, this Agreement
constitutes the entire agreement among the parties pertaining to the subject matter hereof, and supersedes and revokes any and all prior or existing agreements, written or oral, relating to the subject matter hereof, and this Agreement shall be
solely determinative of the subject matter hereof. 

  
 27 

 8. Restrictive Covenants; Confidential Information; Work Product;
Injunctive Relief. 
 8.1. No Material Competition.  

(a) Employer and Employee acknowledge and agree that a strong relationship and connection exists between Employer and its
current and prospective patients, referral sources, and customers as well as the hospitals and healthcare facilities at which it provides professional services. Employer and Employee further acknowledge and agree that the restrictive covenants
described in this Section are designed to enforce, and are ancillary to or part of, the promises contained in this Agreement and are reasonably necessary to protect the legitimate interests of Employer in the following: (i) the use and
disclosure of the Confidential Information as described in Section 8.4; and (ii) the professional development activities described in Section 1.2. The foregoing listing is by way of example only and shall not be construed to be an
exclusive or exhaustive list of such interests. Employee acknowledges that the restrictive covenants set forth below are of significant value to Employer and were a material inducement to Employer in agreeing to the terms of this Agreement. Employee
further acknowledges that the goodwill and other proprietary interest of Employer will suffer irreparable and continuing damage in the event Employee enters into competition with Employer in violation of this Section. 

Therefore, Employee agrees that, except with respect to services performed under this Agreement on behalf of Employer,
Employee shall not 

  
 28 

 
(without the consent of Employee’s Supervisor, which consent may be granted or withheld in the sole discretion of Employee’s Supervisor), at any time during the Restricted Period (as
defined below) for any reason, for Employee or on behalf of any other person, persons, firm, partnership, corporation or employer, participate or engage in or own an interest in, directly or indirectly, any individual proprietorship, partnership,
corporation, joint venture, trust or other form of business entity, whether as an individual proprietor, partner, joint venturer, officer, director, member, employee, consultant, independent contractor, stockholder, lender, landlord, finder, agent,
broker, trustee, or in any manner whatsoever, if such entity or its affiliates is engaged in, directly or indirectly, “Employer’s Business,” as defined on Exhibit A hereto. Employee acknowledges that, as of the date hereof,
Employee’s responsibilities will include matters affecting the businesses of Employer listed on Exhibit A. 

(b) Medical Services in Florida. Employee acknowledges that Employee’s duties under this Agreement have
included Employee’s active leadership relating to medical practices owned or operated by Employer and by an affiliate of Employer in the State of Florida. Employee further acknowledges that Employer and Employer’s affiliates in Florida
have a substantial investment in such medical practices and that Employer and Employer’s affiliates would be economically injured due to lost income in a material amount in the event Employee competes with Employer or any of Employer’s
affiliates in their primary market areas in Florida. Accordingly, Employee agrees that Employee shall not (without the consent of Employee’s Supervisor, which consent may be granted or withheld in the sole discretion of Employee’s
Supervisor), at any time during the Restricted Period, for any reason, for Employee or on behalf of any other person, persons, firm, partnership, corporation or employer, provide professional medical services in any of the clinical practice areas
described as 

  
 29 

 
Employer’s Business on Exhibit A within a radius of twenty (20) miles of a medical practice owned or operated by Employer or any of Employer’s affiliates in Florida. 

For purposes of this Section 8, the “Restricted Period” shall mean the Employment Period plus (i) twenty-four
(24) months in the event this Agreement is terminated pursuant to Section 4.4, 4.7 or 4.8, or (ii) twelve (12) months in the event this Agreement is terminated for any other reason. 

8.2. No Hire. Employee further agrees that Employee shall not (without the consent of Employee’s Supervisor,
which consent may be granted or withheld in the sole discretion of Employee’s Supervisor), at any time during the Restricted Period, for any reason, for Employee or on behalf of any other person, persons, firm, partnership, corporation or
employer, employ, or knowingly permit any company or business directly or indirectly controlled by Employee to employ or otherwise engage (a) any person who is a then current employee or independent contractor of Employer or one of its
affiliates, or (b) any person who was an employee or independent contractor of Employer or one of its affiliates in the prior six (6) month period, or in any manner seek to induce such persons to leave his or her employment or engagement
with Employer or one of its affiliates (including without limitation for or on behalf of a subsequent employer of Employee). Notwithstanding the foregoing, it shall not be a violation of this Section for Employee to participate in any capacity in a
business venture after termination of this Agreement with a current or former employee or independent contractor of Employer or its affiliates if (i) Employee’s participation in such business venture does not violate Section 8.1,
(ii) Employee and such individual were actively pursuing such business venture for a period of at least six (6) months while both were employed or otherwise engaged by Employer, and (iii) a period of at least one (1) year has
elapsed since the termination of Employee’s employment. Additionally, it shall not be a violation of this Section 

  
 30 

 
for Employee to hire one of his administrative assistants at the time of his termination for the purposes of Section 5.16 of this Agreement, or for any other purpose. 

8.3. Non-solicitation. Employee further agrees that Employee shall not (without the consent of Employee’s
Supervisor, which consent may be granted or withheld in the sole discretion of Employee’s Supervisor), at any time during the Restricted Period, for any reason, for Employee or on behalf of any other person, persons, firm, partnership,
corporation or employer, solicit or accept business from or take any action that would interfere with, diminish or impair the valuable relationships that Employer or its affiliates have with (i) hospitals or other health care facilities with
which Employer or its affiliates have contracts to render professional services or otherwise have established relationships, (ii) patients, (iii) referral sources, (iv) vendors, (v) any other clients of Employer or its
affiliates, or (vi) prospective hospitals, patients, referral sources, vendors or clients whose business Employee was aware that Employer or any affiliate of Employer was in the process of soliciting at the time of Employee’s termination
(including potential acquisition targets). 
 8.4. Confidential Information. At all times during the term
of this Agreement, Employer shall provide Employee with access to “Confidential Information.” As used in this Agreement, the term “Confidential Information” means any and all confidential, proprietary or trade secret information,
whether disclosed, directly or indirectly, verbally, in writing or by any other means in tangible or intangible form, including that which is conceived or developed by Employee, applicable to or in any way related to: (i) patients with whom
Employer has a physician/patient relationship; (ii) the present or future business of Employer; or (iii) the research and development of Employer. Without limiting the generality of the foregoing, Confidential Information includes:
(a) the development and operation of Employer’s medical practices, including 

  
 31 

 
information relating to budgeting, staffing needs, marketing, research, hospital relationships, equipment capabilities, and other information concerning such facilities and operations and
specifically including the procedures and business plans developed by Employer for use at the hospitals where Employer conducts its business; (b) contractual arrangements between Employer and insurers or managed care associations or other
payors; (c) the databases of Employer; (d) the clinical and research protocols of Employer, including coding guidelines; (e) the referral sources of Employer; and (f) other confidential information of Employer that is not
generally known to the public that gives Employer the opportunity to obtain an advantage over competitors who do not know or use it, including the names, addresses, telephone numbers or special needs of any of its patients, its patient lists, its
marketing methods and related data, lists or other written records used in Employer’s business, compensation paid to employees and other terms of employment, accounting ledgers and financial statements, contracts and licenses, business systems,
business plan and projections, and computer programs. The parties agree that, as between them, this Confidential Information constitutes important, material, and confidential trade secrets that affect the successful conduct of Employer’s
business and its goodwill. Employer acknowledges that the Confidential Information specifically enumerated above is special and unique information and is not information that would be considered a part of the general knowledge and skill Employee has
or might otherwise obtain. 
 Notwithstanding the foregoing, Confidential Information shall not include any
information that (i) was known by Employee from a third party source before disclosure by or on behalf of Employer, (ii) becomes available to Employee from a source other than Employer that is not, to Employee’s knowledge, bound by a
duty of confidentiality to Employer, (iii) becomes generally available or known in the industry other than as a result of its disclosure by Employee, or (iv) has been independently developed by Employee and may be disclosed by Employee
without breach of this Agreement, provided, in each case, that Employee shall bear the burden of demonstrating that the information falls under one of the above-described exceptions. 

  
 32 

 Employee agrees that, except as required in the performance of
Employee’s duties as an employee of Employer, Employee will not at any time (without the consent of Employee’s Supervisor, which consent may be granted or withheld in the sole discretion of Employee’s Supervisor), whether during or
subsequent to the term of Employee’s employment with Employer, in any fashion, form or manner, unless specifically consented to in writing by Employer, either directly or indirectly, use or divulge, disclose, or communicate to any person, firm
or corporation, in any manner whatsoever, any Confidential Information of any kind, nature, or description, subject to applicable law. In the event that Employee is requested or ordered to disclose any Confidential Information, whether in a legal or
a regulatory proceeding or otherwise, Employee shall provide Employer with prompt written notice of such request or order so that Employer may seek to prevent disclosure or, if that cannot be achieved, the entry of a protective order or other
appropriate protective device or procedure in order to assure, to the extent practicable, compliance with the provisions of this Agreement. In the case of any disclosure required by law, Employee shall disclose only that portion of the Confidential
Information that Employee is ordered to disclose in a legally binding subpoena, demand or similar order issued pursuant to a legal or regulatory proceeding. 
 All Confidential Information, and all equipment, notebooks, documents, memoranda, reports, files, samples, books, correspondence, lists, other written and graphic records, in any media (including
electronic or video) containing Confidential Information or relating to the business of Employer, which Employee shall prepare, use, construct, observe, possess, or control shall be and remain Employer’s sole property (collectively
“Employer Property”). Upon termination or expiration of this Agreement, or earlier upon Employer’s request, Employee shall promptly deliver to Employer all Employer Property, retaining none. 

  
 33 

 8.5. Ownership of Work Product. Employee agrees and acknowledges that
all copyrights, patents, trade secrets, trademarks, service marks, or other intellectual property or proprietary rights associated with any ideas, concepts, techniques, inventions, processes, or works of authorship developed or created by Employee
during the course of performing work for Employer and any other work product conceived, created, designed, developed or contributed by Employee during the term of this Agreement that relates in any way to Employer’s Business (collectively, the
“Work Product”), shall belong exclusively to Employer and shall, to the extent possible, be considered a work made for hire within the meaning of Title 17 of the United States Code. To the extent the Work Product may not be considered a
work made for hire owned exclusively by Employer, Employee hereby assigns to Employer all right, title, and interest worldwide in and to such Work Product at the time of its creation, without any requirement of further consideration. Upon request of
Employer, Employee shall take such further actions and execute such further documents as Employer may deem necessary or desirable to further the purposes of this Agreement, including without limitation separate assignments of all right, title, and
interest in and to all rights of copyright and all right, title, and interest in and to any inventions or patents and any reissues or extensions which may be granted therefor, and in and to any improvements, additions to, or modifications thereto,
which Employee may acquire by invention or otherwise, the same to be held and enjoyed by Employer for its own use and benefit, and for the use and benefit of Employer’s successors and assigns, as fully and as entirely as the same might be held
by Employee had this assignment not been made. 

  
 34 

 8.6. Clearance Procedure for Proprietary Rights Not Claimed by
Employer. In the event that Employee wishes to create or develop, other than on Employer’s time or using Employer’s resources, anything that may be considered Work Product but of which Employee believes Employee should be
entitled to the personal benefit, Employee agrees to follow the clearance procedure set forth in this Section 8.6. Before beginning any such work, Employee agrees to give Employer advance written notice and provide Employer with a sufficiently
detailed written description of the work under consideration for Employer to make a determination regarding the work. Unless otherwise agreed in a writing signed by Employer prior to receipt, Employer shall have no obligation of confidentiality with
respect to such request or description. Employer will determine in its sole discretion, within thirty (30) days after Employee has fully disclosed such plans to Employer, whether rights in such work will be claimed by Employer. If Employer
determines that it does not claim rights in such work, Employer agrees to so notify Employee in writing and Employee may retain ownership of the work to the extent that such work has been expressly disclosed to Employer. If Employer fails to so
notify Employee within such thirty (30) day period, then Employer shall be deemed to have agreed that such work is not considered Work Product for purposes of this Agreement. Employee agrees to submit for further review any significant
improvement, modification, or adaptation that could reasonably be related to Employer’s Business so that it can be determined by Employer whether the improvement, modification, or adaptation relates to the business or interests of Employer.
Clearance under this procedure does not relieve Employee of the restrictive covenants set forth in this Section 8. 
 8.7. Non-Disparagement and Medical Malpractice Cases. Employer agrees that for a period of ten (10) years after the termination of this Agreement, Employer shall not disparage Employee or
otherwise impugn Employee’s name or reputation. Employee agrees that for a period of ten (10) years after the 

  
 35 

 
termination of this Agreement, Employee shall not (i) disparage Employer or any of Employer’s affiliates (including any present, future or former agent, attorney, employee, officer or
director of Employer or any of Employer’s affiliates); (ii) impugn in any manner the name or reputation of Employer or any of Employer’s affiliates (including any present, future or former agent, attorney, employee, officer or
director of Employer or any of Employer’s affiliates); or (iii) speak or write anything disparaging or critical of Employee’s work conditions or the circumstances of the termination of Employee’s employment with Employer.
Furthermore, for a period of ten (10) years after the termination of this Agreement, Employee shall not serve as a medical consultant or expert witness for any person or entity (including any attorney for such person or entity) in any lawsuit
or other proceeding against Employer or any Related Person (as hereinafter defined). For purposes of this Section 8.7, each of the following is a Related Person: (a) every present, future and former affiliate of Employer; (b) every
present, future and former agent, employee, officer and director of Employer or any affiliate of Employer; and (c) every hospital at which professionals affiliated with Employer have provided services at any time material to the lawsuit or
other proceeding. 
 8.8. Review by Employee. Employee has carefully read and considered the terms and
provisions of this Section 8, and having done so, agrees that the restrictions set forth in this Section 8 are fair and reasonably required for the protection of the interests of Employer. Without limiting other possible remedies available
to Employer, Employee agrees that injunctive or other equitable relief will be available to enforce the covenants set forth in this Section, such relief to be without the necessity of posting a bond. In the event that, notwithstanding the foregoing,
any part of the covenants set forth in this Section 8 shall be held to be invalid, overbroad, or unenforceable by an arbitration panel or a court of competent jurisdiction, the parties hereto agree that such invalid, overbroad, or unenforceable
provision(s) may be modified or severed from this Agreement 

  
 36 

 
without, in any manner, affecting the remaining portions of this Section 8 (all of which shall remain in full force and effect). In the event that any provision of this Section 8
related to time period or areas of restriction shall be declared by an arbitration panel or a court of competent jurisdiction to exceed the maximum time period, area or activities such arbitration panel or court deems reasonable and enforceable,
said time period or areas of restriction shall be deemed modified to the minimum extent necessary to make the geographic or temporal restrictions or activities reasonable and enforceable. 

8.9. Survival and Termination of Payments and Benefits. The provisions of this Section 8 shall survive the
termination of this Agreement and Employee’s employment with Employer. If Employee fails to comply fully with any provision of this Section 8, Employee shall not be entitled to receive any further payments or benefits of any kind under
Section 5 of this Agreement (other than Base Salary through date of termination and any amounts and/or benefits due under Section 5.9, 5.10, or 5.13 hereof) and Employer shall have the right to terminate without advance notice any and all
other future payments and benefits of every kind that otherwise would be due under Section 5 of this Agreement. The provisions of this Section 8 are expressly intended to benefit and be enforceable by other affiliated entities of Employer,
who are express third party beneficiaries hereof. Employee shall not assist others in engaging in any of the activities described in the foregoing restrictive covenants. 
 9. Arbitration. Any controversy or claim arising out of or relating to this Agreement, or any alleged breach hereof shall be finally determined by binding arbitration before a three member panel,
consisting of one member selected by each party hereto, with the third member selected by the first two arbitrators. Each party hereto shall bear the costs of its own nominee, and shall share equally the cost of the third arbitrator and the parties
agree that the costs of arbitration shall not be subject to reapportionment by the arbitration panel. The arbitration proceedings shall be held in 

  
 37 

 
Sunrise, Florida, unless otherwise mutually agreed by the parties, and shall be conducted in accordance with the Employment Arbitration Rules and Mediation Procedures of the American Arbitration
Association then in effect and any judgment or award rendered by the arbitration panel may be entered and enforced by any court having jurisdiction thereof. Notwithstanding anything herein to the contrary, if Employer shall require immediate
injunctive relief, then Employer shall be entitled to seek such relief in any court having jurisdiction, and if Employer elects to do so, Employee hereby consents to the jurisdiction of the state and federal courts sitting in the State of Florida
and to the applicable service of process. Employee hereby waives and agrees not to assert, to the fullest extent permitted by applicable law, any claim that (i) Employee is not subject to the jurisdiction of such courts, (ii) Employee is
immune from any legal process issued by such courts and (iii) any litigation or other proceeding commenced in such courts is brought in an inconvenient forum. Any such arbitration shall be treated as confidential by all parties thereto, except
as otherwise provided by law or as otherwise necessary to enforce any judgment or order issued by the arbitrators. 
 10.
Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of Florida without regard to its conflict of laws principles to the extent that such principles would require the application of laws other
than the laws of the State of Florida. 
 11. Notices. Any notice required or permitted to be given under this Agreement
shall be in writing and shall be deemed to have been given when delivered by hand or when deposited in the United States mail by registered or certified mail, return receipt requested, postage prepaid, addressed as follows: 

 

			
	If to Employer:	  	If to Employee:
		
	Mednax Services, Inc.	  	Roger J. Medel, M.D.
	1301 Concord Terrace	  	c/o Mednax Services, Inc.
	Sunrise, FL 33323	  	1301 Concord Terrace
	Attention: General Counsel	  	Sunrise, FL 33323

  
 38 

 or to such other addresses as either party hereto may require to give proper notice to the other in the
aforesaid manner. 
 12. Benefits: Binding Effect. This Agreement shall be for the benefit of and binding upon the
parties hereto and their respective heirs, personal representatives, legal representatives, successors and, where applicable, assigns. Notwithstanding the foregoing, Employee may not assign the rights or benefits hereunder without the prior written
consent of Employer. 
 13. Severability. The invalidity of any one or more of the words, phrases, sentences, clauses or
Sections contained in this Agreement shall not affect the enforceability of the remaining portions of this Agreement or any part thereof. 
 14. Waivers. The waiver by either party hereto of a breach or violation of any term or provision of this Agreement shall not operate nor be construed as a waiver of any subsequent breach or
violation. 
 15. Damages. Nothing contained herein shall be construed to prevent Employer or Employee from seeking and
recovering from the other damages sustained by either or both of them as a result of a breach of any term or provision of this Agreement. In the event of any controversy or claim arising out of or relating to this Agreement, each party will bear its
own costs for arbitration or court and attorneys’ fees. 

  
 39 

 16. No Third Party Beneficiary. Except as provided in Section 8.9, nothing
expressed or implied in this Agreement is intended, or shall be construed, to confer upon or give any person (other than the parties hereto and, in the case of Employee, Employee’s heirs, personal representative(s) and/or legal representative)
any rights or remedies under or by reason of this Agreement. No agreements or representations, oral or otherwise, express or implied, have been made by either party with respect to the subject matter of this Agreement which agreements or
representations are not set forth expressly in this Agreement, and this Agreement supersedes any other agreement between Employer and Employee. 
 17. Headings. The section headings in this Agreement are solely for convenience of reference and form no part of this Agreement. 

IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the date first above written. 

 

							
	EMPLOYER:	 		 	EMPLOYEE:
			
	MEDNAX SERVICES, INC.	 		 	
				
	By:	 	 /s/ Michael B. Fernandez
	 		 	 /s/ Roger J. Medel, M.D.

		 	Michael B. Fernandez	 		 	Roger J. Medel, M.D.
		 	Chairman, Compensation Committee	 		 	

  
 40 

 EXHIBIT A 
 BUSINESS OF EMPLOYER 
 As of the date hereof, Employer, directly or through
its affiliates, provides professional medical services and all aspects of practice management services in medical practice areas that include, but are not limited to, the following (collectively referred to herein as “Employer’s
Business”): 
 (1) Neonatology, including hospital well baby care; 

(2) Maternal-Fetal Medicine, including general obstetrics services; 

(3) Pediatric Cardiology; 
 (4) Pediatric Intensive Care, including Pediatric Hospitalist Care; 

(5) Anesthesiology; and 
 (6) Newborn hearing screening services; 
 References to Employer’s
Business in this Agreement shall include such other medical service lines, practice management services and other businesses entered into by Employer after the date hereof but during the term of this Agreement; provided, that to be considered
a part of Employer’s Business, Employer must have engaged in such other service line, practice management service or other business at least six (6) months prior to the termination date of this Agreement. For purposes of this Exhibit A,
businesses of Employer shall include the businesses conducted by Employer’s subsidiaries, entities under common control and affiliates as defined under Rule 144 of the Securities Act of 1933, as amended. Such affiliates shall include the
professional corporations and associations whose operating results are consolidated with Employer for financial reporting purposes. 

  
 1 

 Notwithstanding the foregoing, Employer acknowledges and agrees to the following exceptions
and clarifications regarding the scope of Employer’s Business. 
 A. Practice Management Services. Employer
acknowledges that, as of the date hereof, Employer’s Business relates to the delivery of both professional and practice management services in the forgoing practice areas. Therefore, as of the date hereof, Employer acknowledges that it would
not be a violation of Section 8.1 of the Agreement for Employee to provide services to a practice management company (such as a billing company or management services organization (MSO)) if such practice management company is not owned by,
affiliated with (as defined under Rule 144 of the Securities Act of 1933, as amended) or under common control with a health care provider that provides services in the medical services areas included in Employer’s Business. Subject to paragraph
C below, the provisions of this paragraph shall not apply to the extent that, after the date hereof, Employer enters into a business that involves the delivery of practice management services to unrelated third parties. 

B. Hospital Services. Employer and Employee acknowledge that, as of the date hereof, Employer does not currently operate
hospitals, hospital systems or universities. Nevertheless, the businesses of hospitals, hospital systems and universities would be the same as Employer’s Business where such hospitals, hospital systems or universities provide some or all of the
medical services included in Employer’s Business. Therefore, the parties desire to clarify their intent with respect to the limitations on Employee’s ability to work for a hospital, hospital system or university after termination of this
Agreement. Section 8.1 shall not be deemed to restrict Employee’s ability to work for a hospital, hospital system or university if the hospital, hospital system or university does not provide any of the medical services included in
Employer’s Business. Furthermore, even if a hospital, hospital system or university provides medical services that are included in Employer’s Business, 

  
 2 

 
Employee may work for such hospital, hospital system or university if (i) Employee has no direct supervisory responsibility for or involvement in the hospital’s, hospital system’s
or university’s medical services that are Employer’s Business, and (ii) Employee would not otherwise violate Section 8.1(b). Finally, Employer agrees that Employee may hold direct supervisory responsibility for or be involved in
the medical services of a hospital, hospital system or university that are included in Employer’s Business so long as such hospital, hospital system or university is located at least ten (10) miles from a medical practice owned or operated
by Employer or its affiliate. Subject to paragraph C below, the provisions of this paragraph shall not apply to the extent that, after the date hereof, Employer enters into the business of operating a hospital or health system. 

C. DeMinimus Exception. Employer agrees that a medical service line (other than those listed in items 1 through 5 above), practice
management service or other business entered into by Employer shall not be considered to be a part of Employer’s Business if such medical service line, practice management service or other business constitutes less than Fifteen Million Dollars
($15,000,000) of Employer’s annual revenues. 
 D. Certain Ownership Interests. It shall not be deemed to be a
violation of Section 8.1 for Employee to: (i) own, directly or indirectly, five percent (5%) or less of a publicly-traded entity; or (ii) own, directly or indirectly, less than five percent (5%) of a privately-held business
or company, if Employee is at all times a passive investor with no board representation, management authority or other special rights to control operations of such business. 

  
 3 

 EXHIBIT B 

FORM OF RELEASE 
 AGREEMENT OF GENERAL RELEASE 
 This Agreement of General Release
(“General Release”) is hereby made and entered into
between                                        
(“Employer”) and ROGER J. MEDEL, M.D. (“Employee”) to be effective as set forth in Section 8 below. 

1. Employee, for himself and his family, heirs, executors, administrators, legal representatives and their respective successors and
assigns, in exchange for the consideration to be provided pursuant to Section 5 of the Employment Agreement entered into by and between Employee and Mednax Services, Inc. (“Employer”). effective as of August     ,
2011, and as thereafter amended, (the “Employment Agreement”) hereby gives up, releases, and discharges Mednax, Inc. “Mednax”), its subsidiaries, affiliated companies, successors and assigns, and its current and former directors,
officers, employees, shareholders and agents in such capacities (collectively with Mednax, Inc, the “Released Parties”) from any and all rights and claims that Employee may have against the Released Parties as of the effective date of this
Agreement arising from or in connection with Employee’s employment or termination of employment with Employer, including without limitation any and all rights and claims to or for attorneys’ fees, whether or not Employee presently is aware
of such rights or claims or suspects them to exist. These rights and claims include, but are not limited to, any and all rights and claims which Employee may have under, or arising out of, the Age Discrimination in Employment Act of 1967, as amended
(the “ADEA”); the Americans with Disabilities Act of 1990, as amended; the Family and Medical Leave Act; Title VII of the Civil Rights Act of 1964, as amended; and any other federal, state or local constitution, statute, ordinance,
executive order, or common law. 
 2. Notwithstanding anything in Paragraph 1 above to the contrary, this General Release shall
not apply to (i) any actions to enforce rights to receive any 

  
 1 

 
payments or benefits which may be due Employee pursuant to Section 5 of the Employment Agreement, or under any of Employer’s employee benefit plans; (ii) any rights or claims that
may arise as a result of events occurring after the date this General Release is signed by Employee, (iii) any indemnification rights Employee may have as a former officer or director of Mednax or its subsidiaries or affiliated companies,
(iv) any claims for benefits under any directors’ and officers’ liability policy maintained by Mednax or its subsidiaries or affiliated companies in accordance with the terms of such policy, and (v) any rights Employee may have
as a holder of equity securities of Mednax . 
 3. Employee represents that he has not filed against the Released Parties any
complaints, charges, or lawsuits arising out of his employment, termination of employment, or any other matter arising on or prior to the date Employee signed this General Release, and covenants and agrees that he will never individually or with any
person or entity file, or commence the filing of, any charge, lawsuit, complaint or proceeding with any governmental agency, or against the Released Parties with respect to any of the matters released by Employee pursuant to Paragraph 1 hereof (a
“Proceeding”); provided, however, Employee retains the right to commence a Proceeding to challenge whether Employee knowingly and voluntarily waived his rights under ADEA. 

4. Employee hereby shall have twenty-one (21) days to sign this General Release, but he may knowingly and voluntarily waive that
twenty-one (21) day period by signing this General Release earlier. Employee shall have seven (7) days following the date on which he signs this General Release within which he may revoke it by providing a written notice of his revocation
to Employer. 
 5. This General Release will be governed by and construed and enforced in accordance with the internal laws of
the State of Florida applicable to contracts made and to be performed entirely within such State. 

  
 2 

 6. Employee acknowledges that he has read this General Release, that he has been advised to
consult with an attorney before he signs this General Release, and that he understands all of its terms and signs it voluntarily and with full knowledge of its significance and the consequences thereof. 

7. If any provision of this General Release, or any part thereof, is determined to be invalid or unenforceable by a court having
jurisdiction in the matter, all of the remaining provisions and parts of this General Release shall remain fully enforceable. 

8. This General Release shall take effect on the eighth day following Employee’s signing it unless Employee’s written
revocation is delivered to Employer within seven (7) days after Employee signs this General Release, in which case this General Release shall be null and void and of no legal effect. 

 

											
	EMPLOYER:	 	 EMPLOYEE:
	 	
			
	MEDNAX, INC.	 		 	
					
	By:	 	  
	 		 	  
	 	
		 	[Name]	 		 	 Roger J. Medel, M.D.
	 	
						
	Date:	 	  
	 		 	 Date:
	 	  
	 	

  
 3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00193-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00193-of-00352.parquet"}]]